Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

C3_LYMPHNODES_SECONDARY_NAS_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C77 Hospital discharge: ICD-8 — 196 Cause of death: ICD-10 — C77 Cause of death: ICD-8 — 196 Cancer registry: Topography ICD-O-3 — C77 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	6029
4. Check minimum number of events None	6029
5. Include endpoints None	6029
6. Filter based on genotype QC (FinnGen only)	6029

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_LYMPHNODES_SECONDARY_NAS_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE_EXALLC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C77
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	196
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C77
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	196
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C77
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Secondary and unspecified malignant neoplasm of lymph nodes

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6029	2703	3326
Unadjusted period prevalence (%)	1.22	0.92	1.47
Median age at first event (years)	65.35	63.64	66.73

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2919: Matched controls
29189

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

PJA10

NOMESCO Finland

Exploration of lymph nodes

159.9

323.0

536

JN4BD

NOMESCO Finland

Extensive body CT

31.1

323.0

1172

616

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3193.7

323.0

836

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

1137.3

323.0

477

JN4AD

NOMESCO Finland

Body CT examination

21.9

323.0

636

366

M04AA01

ATC

allopurinol; systemic

8.6

323.0

1249

2331

L03AA02

ATC

filgrastim; parenteral

984.0

323.0

793

A04AA02

ATC

granisetron; systemic, transdermal

670.0

323.0

548

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

755.9

323.0

394

JN6AD

NOMESCO Finland

CT of torso and neck

130.6

323.0

356

A03FA01

ATC

metoclopramide; systemic, rectal

19.3

323.0

1586

1695

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

+∞

323.0

305

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

66.2

323.0

901

195

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

323.0

392

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

94.3

323.0

552

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

1854.5

323.0

589

H02AB02

ATC

dexamethasone; systemic

66.7

323.0

571

106

L03AA13

ATC

pegfilgrastim; parenteral

3558.1

323.0

597

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

323.0

409

A04AA01

ATC

ondansetron; systemic, rectal

38.3

323.0

689

233

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

231.5

323.0

704

XW000

NOMESCO Finland

Bone marrow biopsy

33.3

323.0

811

333

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

323.0

531

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

323.0

343

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

484.1

323.0

2101

154

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

323.0

877

WW500

NOMESCO Finland

Blood transfusion

24.1

313.3

457

223

WF002

NOMESCO Finland

Radical radiotherapy

246.5

284.9

289

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

2856.7

284.9

271

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

27.3

267.4

375

157

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

9.8

259.4

563

693

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

259.3

245

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

4.3

258.2

1277

4462

WF003

NOMESCO Finland

Adjuvant radiotherapy

648.0

244.8

239

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

+∞

242.1

229

ZX120

NOMESCO Finland

Intravenous

7.6

241.1

619

994

EP1AE

NOMESCO Finland

Neck ultrasound examination

12.7

239.5

450

414

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

1234.5

236.7

228

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

177.3

234.9

244

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

356.0

232.7

232

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

231.4

219

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

227.1

215

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

94.3

226.4

250

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

+∞

221.7

210

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

583.2

221.4

217

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

56.9

219.1

260

1XC02

NOMESCO Finland

78.7

217.8

246

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

215.3

204

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

214.2

203

WF049

NOMESCO Finland

Radiotherapy of metastasis

+∞

214.2

203

D70.82

ICD-10 Finland

Drug-induced neutropenia

78.2

210.5

238

A49.9

ICD-10 Finland

Bacterial infection, unspecified

5.8

206.9

657

1382

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

79.8

203.1

229

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

+∞

198.2

188

C61

ICD-10 Finland

Malignant neoplasm of prostate

289.2

187.2

189

R50.9

ICD-10 Finland

Fever, unspecified

4.7

186.1

731

1928

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

184.3

175

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

184.3

175

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

183.3

174

H02AB06

ATC

prednisolone; systemic

3.1

181.7

1748

9476

C81.0

ICD-10 Finland

Nodular lymphocyte predominant Hodgkin lymphoma

+∞

181.1

172

XX3DW

NOMESCO Finland

Time consuming IT work

9.0

181.1

409

521

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

179.0

170

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

176.9

168

9691/3-C77.9

ICD-O-3

Follicular lymphoma, grade 2 of lymph node, NOS

+∞

176.9

168

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

141.8

175.5

186

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

10.5

173.7

356

380

N02AA05

ATC

oxycodone; systemic

4.9

171.9

641

1587

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.0

168.2

1593

8367

Z51.5

ICD-10 Finland

Palliative care

15.6

166.4

282

199

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

434.1

166.3

165

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

165.2

157

130

Kela drug reimbursment

Malignant tumour

+∞

164.1

156

ZX112

NOMESCO Finland

Subcutaneous

41.7

163.7

206

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

94.8

161.2

178

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

4.4

161.0

665

1815

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

155.6

148

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

95.9

147.8

163

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

98.9

144.7

159

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

25.9

143.4

203

PJA12

NOMESCO Finland

Sentinel node biopsy

361.4

139.0

139

WF004

NOMESCO Finland

Palliative radiotherapy

+∞

134.4

128

9663/3-C77.9

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of lymph node, NOS

+∞

133.3

127

C81.2

ICD-10 Finland

Mixed cellularity classical Hodgkin lymphoma

+∞

131.2

125

C81.7

ICD-10 Finland

Other classical Hodgkin lymphoma

+∞

128.1

122

115

Kela drug reimbursment

Breast cancer

+∞

127.0

121

A02BC02

ATC

pantoprazole; systemic

2.6

122.5

2054

13932

ZX070

NOMESCO Finland

Intensity modified radiotherapy

+∞

121.7

116

A04AA55

ATC

palonosetron, combinations; systemic

1206.2

119.7

116

9591/3-C77.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS

+∞

119.6

114

WW300

NOMESCO Finland

Transfer of autologic stem cells

+∞

117.5

112

H02AB07

ATC

prednisone; oral

3.4

116.2

662

2314

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

+∞

110.1

105

JN4CD

NOMESCO Finland

Very extensive body CT

12.2

108.4

203

177

A04AD12

ATC

aprepitant; systemic

547.5

107.5

106

ZX090

NOMESCO Finland

Other technic of radiotherapy

192.2

107.2

111

J01MA12

ATC

levofloxacin; systemic

3.0

106.6

735

2923

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

11.3

106.2

207

196

9591/3-C77.0

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck

+∞

105.9

101

TPX10

NOMESCO Finland

Implantation of vascular injection port

12.7

104.9

193

162

XX9CD

NOMESCO Finland

Very extensive complementary CT

+∞

102.7

WZC30

NOMESCO Finland

Teaching

3.9

102.7

469

1355

WX408

NOMESCO Finland

General anesthesy, balanced

2.7

102.1

881

4018

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

6.6

100.7

275

453

J05AB11

ATC

valaciclovir; oral

3.4

95.7

542

1857

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.3

94.1

307

630

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

326.7

93.4

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

93.2

116

Kela drug reimbursment

Prostate cancer

+∞

92.2

L01AA02

ATC

chlorambucil; oral

194.1

90.8

B01AB05

ATC

enoxaparin; parenteral

2.4

88.4

947

4797

Z85.7

ICD-10 Finland

Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues

+∞

87.9

9663/3-C77.8

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of multiple regions

+∞

87.9

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

86.9

9823/3-C77.9

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph node, NOS

+∞

85.8

20199

ICD-8 Finland

Hodgkin's disease

+∞

85.8

2008X

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Other named variants

+∞

85.8

212

Kela drug reimbursment

Gout

8.4

85.7

197

250

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

9.5

83.2

177

197

HA1AA

NOMESCO Finland

X-ray mammography

8.6

82.9

187

230

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

218.7

82.8

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

34.7

82.0

107

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

40.6

80.9

102

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

79.5

B72

ICPC

Hodgkin Lymphoma

+∞

78.5

JN4ED

NOMESCO Finland

Body CT examination with specail preparation

778.4

77.7

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

16.4

76.9

126

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

76.4

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.5

75.9

390

1224

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

75.3

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

5.4

75.0

240

478

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

8.0

73.6

173

227

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

77.7

73.5

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

102.8

73.2

9691/3-C77.8

ICD-O-3

Follicular lymphoma, grade 2 of lymph nodes of multiple regions

+∞

73.2

9650/3-C77.0

ICD-O-3

Hodgkin lymphoma, NOS, of lymph nodes of head, face and neck

+∞

73.2

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

68.3

692

3326

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

68.0

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

67.5

839

4453

9690/3-C77.9

ICD-O-3

Follicular lymphoma, NOS, of lymph node, NOS

+∞

66.9

9698/3-C77.9

ICD-O-3

Follicular lymphoma, grade 3 of lymph node, NOS

+∞

66.9

A79

ICPC

Malignancy NOS

+∞

63.8

L01CB01

ATC

etoposide; systemic

+∞

63.8

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.2

63.5

777

4076

B01AB10

ATC

tinzaparin; parenteral

4.8

63.4

224

496

TGC00

NOMESCO Finland

Bronchial lavation

6.9

61.8

161

246

9663/3-C77.0

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of head, face and neck

+∞

61.7

D70.89

ICD-10 Finland

Neutropenic splenomegaly

16.1

60.9

100

9591/3-C77.2

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of intra-abdominal lymph nodes

+∞

59.6

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

22.4

59.5

HAC20

NOMESCO Finland

Total mastectomy

109.0

59.0

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

58.5

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.5

57.6

296

920

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.5

57.3

294

913

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

568.8

56.8

WW409

NOMESCO Finland

Other aferesis

292.2

56.4

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

11.5

56.3

107

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

8.4

55.8

126

155

ZX080

NOMESCO Finland

Image guided radiotherapy

558.3

55.8

9695/3-C77.9

ICD-O-3

Follicular lymphoma, grade 1 of lymph node, NOS

+∞

55.4

9673/3-C77.9

ICD-O-3

Mantle cell lymphoma of lymph node, NOS

+∞

55.4

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

54.3

9591/3-C77.4

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of inguinal region or leg

+∞

54.3

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

537.5

53.7

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

47.4

53.4

WX110

NOMESCO Finland

Local anesthesy

1.8

53.3

1854

14169

2000B

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]

+∞

53.3

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

5.2

53.1

173

350

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

186.7

53.1

WX402

NOMESCO Finland

General anaesthesia

2.6

53.0

441

1879

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

527.1

52.6

D47.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified

67.9

52.3

TPJ00

NOMESCO Finland

Biopsy of superficial lymph node

270.6

52.3

2015X

ICD-9 Finland

Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, NUD]

+∞

52.2

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

51.4

533

2547

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.3

51.0

281

918

ZX108

NOMESCO Finland

Inhalation

21.7

50.2

C96.9

ICD-10 Finland

Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified

+∞

50.1

L01BC06

ATC

capecitabine; oral

+∞

50.1

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.8

49.5

221

610

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

254.3

49.2

L02AE02

ATC

leuprorelin; implant, parenteral

16.9

49.2

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

+∞

49.1

C83.89

ICD-10 Finland

Other types of diffuse non-Hodgkin's lymphoma

+∞

49.1

N02BE01

ATC

paracetamol; systemic, rectal

2.0

48.2

2411

20500

9680/3-C77.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of head, face and neck

+∞

48.0

C50.99

ICD-10 Finland

Breast, unspecified

+∞

48.0

1AA09

NOMESCO Finland

+∞

48.0

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

42.9

47.7

4701

FHL

Neck lymph node removal

48.4

47.1

WW402

NOMESCO Finland

Leucoferesis

+∞

47.0

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.6

46.9

371

1531

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.7

46.7

340

1335

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

10.2

46.6

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

32.8

46.5

Y77

ICPC

Malignant neoplasm prostate

238.7

46.1

L04.0

ICD-10 Finland

Acute lymphadenitis of face, head and neck

12.7

46.0

XW4XT

NOMESCO Finland

Biopsy of other inner organ with radiological guidance guidance

162.6

45.9

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

162.6

45.9

A07AA02

ATC

nystatin; oral

3.3

45.5

248

803

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

+∞

44.9

Z51.0

ICD-10 Finland

Radiotherapy session

+∞

44.9

9673/3-C77.8

ICD-O-3

Mantle cell lymphoma of lymph nodes of multiple regions

+∞

44.9

2009X

ICD-9 Finland

Lymphosarcoma and reticulosarcoma[LYMPHOMA MALIGNUM (NON-HODGKIN) NUD]

+∞

43.9

C83.33

ICD-10 Finland

Primary medical lymphoma with large B cells

+∞

43.9

L02BG04

ATC

letrozole; oral

13.7

43.5

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

3.8

43.2

196

548

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

42.8

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

42.8

A41.9

ICD-10 Finland

Sepsis, unspecified

4.2

42.3

167

412

TPX15

NOMESCO Finland

Removal of vascular injection port

62.2

42.3

C84.51

ICD-10 Finland

Other and unspecified T-cell lymphomas

+∞

41.8

C83.0

ICD-10 Finland

Small cell B-cell lymphoma

+∞

41.8

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

41.7

598

3273

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

7.1

39.7

100

146

C84.59

ICD-10 Finland

Other and unspecified T-cell lymphomas

+∞

39.7

9698/3-C77.8

ICD-O-3

Follicular lymphoma, grade 3 of lymph nodes of multiple regions

+∞

39.7

HAB40

NOMESCO Finland

Wedge excision of mammary gland

20.7

39.6

J05AB01

ATC

aciclovir; systemic

2.0

39.6

602

3360

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.9

39.3

172

466

YNB10

NOMESCO Finland

Collection of stem cells for transplant

392.5

39.1

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

36.3

39.1

L02BA01

ATC

tamoxifen; oral

47.7

38.9

JAH00

NOMESCO Finland

Laparotomy

5.8

38.6

112

198

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

37.6

D64.9

ICD-10 Finland

Anaemia, unspecified

2.4

37.6

341

1506

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

10.2

37.5

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

371.9

37.1

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

23.4

37.1

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

36.9

511

2740

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

36.5

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

36.5

C83.32

ICD-10 Finland

Centroblastic diffuse non-Hodgkin's lymphoma

+∞

36.5

9652/3-C77.9

ICD-O-3

Hodgkin lymphoma, mixed cellularity, NOS, of lymph node, NOS

+∞

36.5

L02BB03

ATC

bicalutamide; oral

+∞

35.5

C83.2

ICD-10 Finland

Mixed small and large cell (diffuse) non-Hodgkin's lymphoma

+∞

35.5

C85.7

ICD-10 Finland

Other specified types of non-Hodgkin lymphoma

+∞

35.5

L01BB05

ATC

fludarabine; systemic

+∞

35.5

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

96.2

34.8

9659/3-C77.9

ICD-O-3

Hodgkin lymphoma, nodular lymphocyte predominant of lymph node, NOS

+∞

34.4

9659/3-C77.8

ICD-O-3

Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of multiple regions

+∞

34.4

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

341.0

34.0

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

3.0

33.9

214

762

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

77.1

33.9

I88.9

ICD-10 Finland

Nonspecific lymphadenitis, unspecified

17.4

33.6

GD1AD

NOMESCO Finland

Thorax CT examination

3.7

33.5

152

425

C81

ICD-10 Finland

Hodgkin lymphoma

+∞

33.4

9699/3-C77.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of lymph node, NOS

+∞

33.4

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

33.4

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

33.4

1325

9903

NK6AN

NOMESCO Finland

Total body bone isotope imaging

28.5

33.3

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

64.1

33.1

J01DB01

ATC

cefalexin; oral

1.7

32.8

2209

18924

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

32.3

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

32.3

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.6

32.2

254

1039

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

32.2

806

5287

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

34.6

31.9

7856A

ICD-9 Finland

Symptoms involving cardiovascular system, Enlargement of lymph nodes

30.4

31.6

C03CA01

ATC

furosemide; systemic

1.7

31.5

881

5956

ZXA00

NOMESCO Finland

Right side

1.7

31.4

762

4942

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

21.2

31.3

C83.01

ICD-10 Finland

Lymphoplasmacytic lymphoma

+∞

31.3

JAH21

NOMESCO Finland

Staging laparoscopy

+∞

31.3

9591/3-C77.1

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of intrathoracic lymph nodes

+∞

31.3

9591/3-C77.8

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of multiple regions

+∞

31.3

C83.35

ICD-10 Finland

T-cell-rich B-cell lymphoma

+∞

31.3

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

31.3

9591/3-C77.3

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of axilla or arm

+∞

31.3

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

31.3

WW200

NOMESCO Finland

Immunization

4.4

31.0

117

277

L57.0

ICD-10 Finland

Actinic keratosis

2.6

30.9

240

972

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

24.2

30.5

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

18.3

30.5

C82.0

ICD-10 Finland

Follicular lymphoma grade I

+∞

30.3

2000A

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM FOLLICULARE]

+∞

30.3

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

+∞

30.3

C90.0

ICD-10 Finland

Multiple myeloma

+∞

30.3

J01MA14

ATC

moxifloxacin; systemic

2.4

30.1

273

1201

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

59.0

30.1

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

5.9

29.9

147

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

5.8

29.9

151

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.8

29.4

129

351

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

4.4

29.3

110

259

C82.7

ICD-10 Finland

Other types of follicular lymphoma

+∞

29.2

C83

ICD-10 Finland

Non-follicular lymphoma

+∞

29.2

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

29.2

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

29.2

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

29.2

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

29.1

796

5325

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.6

29.0

221

884

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

294.7

28.8

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

104.4

28.7

TAB00

NOMESCO Finland

Lumbar puncture

3.3

28.6

149

466

Z31.6

ICD-10 Finland

General counselling and advice on procreation

13.0

28.4

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.7

28.3

126

347

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

4.1

28.2

112

279

PJ2HT

NOMESCO Finland

Biopsy of deep lymphnode with ultrasound guidance

+∞

28.2

20298

ICD-8 Finland

Other neoplasms of lymphoid tissue, Lymphomata alia

+∞

28.2

9650/3-C77.1

ICD-O-3

Hodgkin lymphoma, NOS, of intrathoracic lymph nodes

+∞

28.2

390

Kela drug reimbursment

Ibrutinib

+∞

28.2

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

28.2

9670/3-C77.9

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph node, NOS

+∞

28.2

2019X

ICD-9 Finland

Hodgkin's disease, unspecified

+∞

28.2

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

28.0

1060

7712

JN3AD

NOMESCO Finland

Abdominal CT examination

2.6

28.0

212

846

R4190

NOMESCO Finland

Nutritional therapy

4.6

27.8

217

A06AH03

ATC

naloxegol; oral

20.8

27.8

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

284.1

27.8

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

21.3

27.4

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

27.1

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

27.1

C83.34

ICD-10 Finland

Anaplastic large cell lymphoma

+∞

27.1

9650/3-C77.9

ICD-O-3

Hodgkin lymphoma, NOS, of lymph node, NOS

+∞

27.1

JAH20

NOMESCO Finland

Staging laparotomy

+∞

27.1

C84.49

ICD-10 Finland

Peripheral T-cell lymphoma, unspecified cell type

+∞

27.1

WX302

NOMESCO Finland

Thoracal epidural anesthesy

4.3

26.9

101

239

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

141.3

26.6

YNB00

NOMESCO Finland

Excision of bone marrow for transplantation

141.3

26.6

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

17.0

26.6

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

9.6

26.4

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

6.4

26.4

111

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

7.0

26.2

9695/3-C77.8

ICD-O-3

Follicular lymphoma, grade 1 of lymph nodes of multiple regions

+∞

26.1

9680/3-C77.2

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of intra-abdominal lymph nodes

+∞

26.1

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

26.1

9690/3-C77.8

ICD-O-3

Follicular lymphoma, NOS, of lymph nodes of multiple regions

+∞

26.1

C91.9

ICD-10 Finland

Lymphoid leukaemia, unspecified

+∞

26.1

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

26.1

D69.5

ICD-10 Finland

Secondary thrombocytopenia

19.7

26.1

AA1BD

NOMESCO Finland

Extensive CT of head and brain

4.7

26.0

196

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

26.0

319

1614

JAH01

NOMESCO Finland

Laparoscopy

3.5

25.8

124

364

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

5.9

25.8

126

H02AB09

ATC

hydrocortisone; systemic

4.7

25.8

193

KCD02

NOMESCO Finland

Transurethral resection of bladder

16.6

25.8

3AA13

NOMESCO Finland

262.8

25.7

C82

ICD-10 Finland

Follicular lymphoma

262.8

25.7

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

262.8

25.7

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

24.3

25.7

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

13.0

25.6

R06AE07

ATC

cetirizine; oral

1.5

25.5

1079

8018

WX002

NOMESCO Finland

Sedation and analgesia

1.7

25.1

546

3394

9652/3-C77.8

ICD-O-3

Hodgkin lymphoma, mixed cellularity, NOS, of lymph nodes of multiple regions

+∞

25.0

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

25.0

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

25.0

C50

ICD-10 Finland

Malignant neoplasm of breast

+∞

25.0

C83.71

ICD-10 Finland

Burkitt's tumour

+∞

25.0

B02

ICPC

Lymph gland(s) enlarged/painful

9.0

25.0

TQW99

NOMESCO Finland

Other minor procedure on skin

3.4

24.9

123

369

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

5.7

24.9

128

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

3.0

24.7

146

497

JAL01

NOMESCO Finland

Laparoscopic biopsy of peritoneum

43.2

24.6

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

27.8

24.5

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

24.0

9652/3-C77.0

ICD-O-3

Hodgkin lymphoma, mixed cellularity, NOS, of lymph nodes of head, face and neck

+∞

24.0

9823/3-C77.8

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of multiple regions

+∞

24.0

GEA00

NOMESCO Finland

Mediastinoscopy

15.2

23.7

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

241.8

23.7

A04AA03

ATC

tropisetron; systemic

241.8

23.7

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

16.0

23.6

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

5.3

23.6

141

ZZR00

NOMESCO Finland

Flap of skin

10.6

23.3

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.8

23.2

153

560

ZXA05

NOMESCO Finland

Left side

1.6

23.2

698

4742

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

6.2

23.1

104

KA1FN

NOMESCO Finland

Isotope renography

12.6

23.1

E83.50

ICD-10 Finland

Hypercalcemia

7.0

23.0

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

22.9

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

22.9

1512

Kela drug reimbursment

Ibrutinib

+∞

22.9

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

22.9

R4110

NOMESCO Finland

Physiotherapy

1.6

22.9

656

4397

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

6.1

22.7

103

JMA10

NOMESCO Finland

Transabdominal total splenectomy

19.1

22.6

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

5.7

22.5

116

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

27.5

22.2

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

3.8

21.9

262

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

+∞

21.9

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

+∞

21.9

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

21.9

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

21.9

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

25.2

21.7

JN4DD

NOMESCO Finland

Scout CT scan of torso

80.7

21.7

V03AF03

ATC

calcium folinate; systemic

221.5

21.6

S18

ICPC

Laceration/cut

1.5

21.6

1051

7975

5702

FHL

Local lymph node removal (eg armpit, groin)

43.7

21.4

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

6.8

21.4

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.6

21.3

167

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

5.5

21.1

117

ED1AA

NOMESCO Finland

Mandipular X-ray examination

12.9

21.1

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

3.6

21.0

267

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

4.6

21.0

161

J02AC03

ATC

voriconazole; systemic

28.2

20.9

9702/3-C77.9

ICD-O-3

Mature T-cell lymphoma, NOS, of lymph node, NOS

+∞

20.9

2016A

ICD-9 Finland

Hodgkin's disease, Mixed cellularity

+∞

20.9

L01XE27

ATC

[U] ibrutinib; oral

+∞

20.9

9690/3-C77.4

ICD-O-3

Follicular lymphoma, NOS, of lymph nodes of inguinal region or leg

+∞

20.9

C81.3

ICD-10 Finland

Lymphocyte depleted classical Hodgkin lymphoma

+∞

20.9

9663/3-C77.1

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of intrathoracic lymph nodes

+∞

20.9

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

20.9

GEA20

NOMESCO Finland

Mediastinoscopy with excision of lesion

18.4

20.4

B02.9

ICD-10 Finland

Zoster without complication

2.4

20.3

179

773

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

8.3

19.9

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

57.9

19.9

6103

FHL

Staging laparotomy (to study the reticuloendothelial system)

+∞

19.8

9691/3-C77.0

ICD-O-3

Follicular lymphoma, grade 2 of lymph nodes of head, face and neck

+∞

19.8

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

19.8

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

+∞

19.8

2014A

ICD-9 Finland

Hodgkin's disease, Lymphocytic-histiocytic predominance[MORBUS HODGKIN,""""LYMPHOCYTIC PREDOMINANCE"""",""""NODULAR""""]

+∞

19.8

9680/3-C77.4

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of inguinal region or leg

+∞

19.8

C83.8

ICD-10 Finland

Other non-follicular lymphoma

+∞

19.8

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

19.8

TPH07

NOMESCO Finland

Cathetrisation of artery

2.1

19.8

244

1235

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

105.7

19.6

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

201.3

19.6

X76

ICPC

Malignant neoplasm breast female

201.3

19.6

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

201.3

19.6

SPAT1153

SPAT

Removal of sutures

1.5

19.5

800

5815

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

19.5

462

2923

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

15.6

19.2

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

7.3

19.2

WF099

NOMESCO Finland

Other radiotherapy

46.3

19.2

A06AD11

ATC

lactulose; oral

1.8

19.1

392

2374

TGD00

NOMESCO Finland

Needle biopsy of lung

18.3

19.1

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

4.5

19.0

150

PJ4AT

NOMESCO Finland

Labeling lymphnode with ultrasound guidance

55.4

18.9

1CX01

NOMESCO Finland

55.4

18.9

A02BC01

ATC

omeprazole; systemic

1.5

18.8

725

5188

C84.5

ICD-10 Finland

Other mature T/NK-cell lymphomas

+∞

18.8

C88.9

ICD-10 Finland

Malignant immunoproliferative disease, unspecified

+∞

18.8

9705/3-C77.9

ICD-O-3

Angioimmunoblastic T-cell lymphoma of lymph node, NOS

+∞

18.8

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

18.8

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

+∞

18.8

9659/3-C77.3

ICD-O-3

Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of axilla or arm

+∞

18.8

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

18.8

9699/3-C77.8

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

18.8

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

18.8

B01AB04

ATC

dalteparin; parenteral

2.6

18.7

135

525

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

15.1

18.4

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

30.2

18.3

TNE20

NOMESCO Finland

Bone marrow aspiration, pelvis

25.2

18.2

JAL00

NOMESCO Finland

Biopsy of peritoneum

25.2

18.2

D48.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other specified sites

8.9

18.1

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

4.7

18.0

132

127

Kela drug reimbursment

Transplant complication

5.0

17.9

119

Z52.89

ICD-10 Finland

Donor of other organ or tissue

67.0

17.7

2015A

ICD-9 Finland

Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, CELLULAR PHASE]

+∞

17.7

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

17.7

I42.7

ICD-10 Finland

Cardiomyopathy due to drugs and other external agents

+∞

17.7

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

17.7

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

17.7

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

17.7

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

17.7

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

17.7

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

+∞

17.7

N02AX02

ATC

tramadol; systemic, rectal

1.4

17.6

1070

8400

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

95.6

17.6

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

181.0

17.5

128

Kela drug reimbursment

Cancers of female genital organs

181.0

17.5

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

8.1

17.5

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

9.6

17.4

UJF32

NOMESCO Finland

Coloscopy

1.5

16.9

638

4527

L01AA01

ATC

cyclophosphamide; systemic

14.1

16.8

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

16.7

664

4770

9690/3-C77.0

ICD-O-3

Follicular lymphoma, NOS, of lymph nodes of head, face and neck

+∞

16.7

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

16.7

9651/3-C77.9

ICD-O-3

Hodgkin lymphoma, lymphocyte-rich of lymph node, NOS

+∞

16.7

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

16.7

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

16.7

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

16.7

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

16.7

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

16.7

158

708

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

170.9

16.5

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

170.9

16.5

L02BG06

ATC

exemestane; oral

170.9

16.5

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

40.3

16.3

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

16.1

220

1158

9101

FHL

Bone biopsy

21.1

16.0

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

4.5

15.7

124

XX1AD

NOMESCO Finland

Other CT-examination

+∞

15.6

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

15.6

9702/3-C77.8

ICD-O-3

Mature T-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

15.6

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

+∞

15.6

C84.4

ICD-10 Finland

Peripheral T-cell lymphoma, not elsewhere classified

+∞

15.6

9680/3-C77.3

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of axilla or arm

+∞

15.6

Z51.3

ICD-10 Finland

Blood transfusion (without reported diagnosis)

+∞

15.6

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

15.6

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

+∞

15.6

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

15.6

L01EL01

ATC

ibrutinib; oral

+∞

15.6

9670/3-C77.0

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of head, face and neck

+∞

15.6

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.5

15.6

213

120

Kela drug reimbursment

Hypogammaglobulinaemia

26.4

15.6

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

26.4

15.6

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.1

15.5

273

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

13.8

15.5

J01MA02

ATC

ciprofloxacin; systemic

1.4

15.4

969

7603

N05CF01

ATC

zopiclone; oral

1.4

15.2

816

6209

J94.8

ICD-10 Finland

Other specified pleural conditions

4.6

15.1

115

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

3.9

14.8

155

D48.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Retroperitoneum

21.1

14.6

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

21.1

14.6

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

14.6

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

14.6

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

14.6

372

Kela drug reimbursment

Idelalisib

+∞

14.6

PJD43

NOMESCO Finland

Excision of aortic lymph nodes

+∞

14.6

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.9

14.6

303

B73

ICPC

Leukaemia

80.5

14.6

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.2

14.5

146

675

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

150.7

14.5

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

150.7

14.5

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

150.7

14.5

104

Kela drug reimbursment

Thyroid insufficiency

2.1

14.5

174

870

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.2

14.4

143

658

A41.8

ICD-10 Finland

Other specified sepsis

3.8

14.1

157

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.7

14.1

369

HAB99

NOMESCO Finland

Other partial excision of mammary gland

6.7

14.0

121

Kela drug reimbursment

Severe hypofunction of sexual glands

3.9

14.0

149

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.6

13.9

102

401

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

30.2

13.9

WX892

NOMESCO Finland

Monitored bed care

1.9

13.8

192

1019

J02AC01

ATC

fluconazole; systemic

1.4

13.6

828

6425

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

5.9

13.6

9651/3-C77.0

ICD-O-3

Hodgkin lymphoma, lymphocyte-rich of lymph nodes of head, face and neck

+∞

13.5

9659/3-C77.0

ICD-O-3

Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of head, face and neck

+∞

13.5

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

13.5

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

13.5

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

+∞

13.5

C83.51

ICD-10 Finland

B-lymphoblastic lymphoma or leukemia

+∞

13.5

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

13.5

C85.0

ICD-10 Finland

Lymphosarcoma

+∞

13.5

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

140.6

13.5

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

13.4

390

2591

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

13.4

520

3697

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

25.8

13.4

J01CA04

ATC

amoxicillin; systemic

1.4

13.3

2060

18576

S04

ICPC

Lump/swelling localized

1.8

13.1

221

1252

H03AA01

ATC

levothyroxine sodium; systemic

1.5

13.1

536

3847

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

4.9

13.1

I89.9

ICD-10 Finland

Noninfective disorder of lymphatic vessels and lymph nodes, unspecified

28.5

12.9

6753

FHL

Transabdominal splenectomy

28.5

12.9

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

12.9

316

2005

UKC02

NOMESCO Finland

Cystoscopy

1.6

12.9

385

2572

EMA10

NOMESCO Finland

Biopsy of tonsil

13.0

12.9

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

12.8

921

7341

N05BA06

ATC

lorazepam; systemic, sublingual

2.1

12.7

139

668

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

10.5

12.7

JFB00

NOMESCO Finland

Partial resection of small intestine

4.4

12.6

104

D37.00

ICD-10 Finland

Aryepiglottic fold marginal zone

12.3

12.6

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.5

12.6

393

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

12.5

228

1325

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

+∞

12.5

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

12.5

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

12.5

20013

ICD-8 Finland

Lymphosarcoma and reticulum-cell sarcoma, Lymphosarcoma loco alio (lymphonodis intrathoracalibus et intra-abdominalibus inclusis)

+∞

12.5

C83.40

ICD-10 Finland

Immunoblast large cell lymphoma

+∞

12.5

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

12.5

8000/3-C80.9

ICD-O-3

Neoplasm, malignant of unknown primary site

+∞

12.5

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

12.5

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

12.5

C83.70

ICD-10 Finland

Non-Hodgkin's lymphoma of the Burkitt type

+∞

12.5

9650/3-C77.8

ICD-O-3

Hodgkin lymphoma, NOS, of lymph nodes of multiple regions

+∞

12.5

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

12.5

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

12.5

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

12.5

PJ2CT

NOMESCO Finland

Biopsy of lymphnode with CT guidance

+∞

12.5

ZX121

NOMESCO Finland

Central venous catheter

17.4

12.5

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.7

12.5

144

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

130.5

12.4

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

130.5

12.4

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

130.5

12.4

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.7

12.4

312

ZXC50

NOMESCO Finland

Cryotherapy

3.3

12.3

182

EBA10

NOMESCO Finland

Surgical removal of tooth

1.7

12.3

247

1483

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

14.4

12.3

WX702

NOMESCO Finland

Supraglottic ventilation device

2.3

12.2

113

504

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.4

12.2

173

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

6.4

12.1

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

12.4

12.1

ZXC15

NOMESCO Finland

Use of photodynamic technique

6.1

12.1

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

7.0

12.1

EP2AT

NOMESCO Finland

Neck soft tissue cytology with ultrasound guidance

18.1

12.0

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

12.0

391

2665

4704

FHL

Neck tumor removal

21.4

12.0

L02BG03

ATC

anastrozole; oral

21.4

12.0

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

30.1

11.6

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.8

11.6

128

TGE00

NOMESCO Finland

Needle biopsy of mediastinum

12.6

11.6

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

12.6

11.6

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

3.5

11.5

150

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

11.5

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

11.5

WW306

NOMESCO Finland

Transfer of stem cells from foreign registered donator

+∞

11.5

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

+∞

11.5

9695/3-C77.0

ICD-O-3

Follicular lymphoma, grade 1 of lymph nodes of head, face and neck

+∞

11.5

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

11.5

9695/3-C77.4

ICD-O-3

Follicular lymphoma, grade 1 of lymph nodes of inguinal region or leg

+∞

11.5

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

11.5

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

11.5

C83.6

ICD-10 Finland

Undifferentiated (diffuse) non-Hodgkin's lymphoma

+∞

11.5

L01XX47

ATC

[U] idelalisib; oral

+∞

11.5

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

11.5

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

11.5

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

11.5

C84.43

ICD-10 Finland

Peripheral T-cell lymphoma, large cell type

+∞

11.5

C84.0

ICD-10 Finland

Mycosis fungoides

+∞

11.5

9698/3-C77.0

ICD-O-3

Follicular lymphoma, grade 3 of lymph nodes of head, face and neck

+∞

11.5

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

+∞

11.5

C83.59

ICD-10 Finland

Lymphoblastic lymphoma of indeterminate type

+∞

11.5

9590/3-C77.9

ICD-O-3

Malignant lymphoma, NOS, of lymph node, NOS

+∞

11.5

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

+∞

11.5

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

11.5

9690/3-C77.2

ICD-O-3

Follicular lymphoma, NOS, of intra-abdominal lymph nodes

+∞

11.5

C83.5

ICD-10 Finland

Lymphoblastic (diffuse) lymphoma

+∞

11.5

6BA02

NOMESCO Finland

13.6

11.4

PJD99

NOMESCO Finland

Excision of other lymph nodes

120.4

11.4

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

120.4

11.4

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

3.8

11.4

125

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

6.4

11.4

S77

ICPC

Malignant neoplasm of skin

15.1

11.3

R16.1

ICD-10 Finland

Splenomegaly, not elsewhere classified

15.1

11.3

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

35.1

11.3

A05AA02

ATC

ursodeoxycholic acid; oral

3.9

11.2

117

R50.8

ICD-10 Finland

Other specified fever

7.3

11.2

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

17.1

11.2

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

4.0

11.1

109

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

3.3

11.0

171

ENA10

NOMESCO Finland

Biopsy of pharynx

11.2

11.0

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

2.5

10.9

342

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

6.0

10.9

Z51.88

ICD-10 Finland

Other specified medical care

3.3

10.8

168

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

6.9

10.8

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

8.9

10.7

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

7.2

10.7

XW4CT

NOMESCO Finland

Biopsy of other inner organ with CT guidance

60.2

10.6

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

5.1

10.6

R05

ICD-10 Finland

Cough

1.4

10.5

459

3329

5701

FHL

Local exploration of lymph nodes (includes biopsy)

110.4

10.4

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

110.4

10.4

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

10.4

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

+∞

10.4

PJ002

NOMESCO Finland

Radical radiotherapy of neck, clavicle and axilla

+∞

10.4

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

10.4

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

10.4

C91.7

ICD-10 Finland

Other lymphoid leukaemia

+∞

10.4

9670/3-C77.8

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of multiple regions

+∞

10.4

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

+∞

10.4

9680/3-C42.1

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of bone marrow

+∞

10.4

9691/3-C77.4

ICD-O-3

Follicular lymphoma, grade 2 of lymph nodes of inguinal region or leg

+∞

10.4

C84.41

ICD-10 Finland

Peripheral T-cell lymphoma, medium-sized cell type

+∞

10.4

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

+∞

10.4

D76.1

ICD-10 Finland

Haemophagocytic lymphohistiocytosis

+∞

10.4

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

10.4

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

5.4

10.4

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.9

10.4

219

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

10.4

794

6352

A02BC05

ATC

esomeprazole; systemic

1.3

10.3

953

7838

DHB00

NOMESCO Finland

Excision of lesion of external nose

12.1

10.3

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.9

10.3

220

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

6.4

10.3

WX720

NOMESCO Finland

Own respiration

2.3

10.3

427

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

18.8

10.3

JMA11

NOMESCO Finland

Laparoscopic total splenectomy

23.4

10.2

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.3

10.2

408

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.1

10.1

109

524

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.7

10.1

119

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.0

10.0

130

673

L02AE03

ATC

goserelin; implant

9.1

10.0

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

40.2

10.0

TQW20

NOMESCO Finland

Tatoe

40.2

10.0

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

5.8

9.9

R60.0

ICD-10 Finland

Localized oedema

1.6

9.8

250

1604

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

9.8

148

809

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

5.4

9.8

N03AX16

ATC

pregabalin; oral

1.4

9.8

531

4006

D59.1

ICD-10 Finland

Other autoimmune haemolytic anaemias

8.7

9.8

J01MA01

ATC

ofloxacin; systemic

1.7

9.7

211

1295

WX725

NOMESCO Finland

Noninvasive ventilation

2.2

9.7

101

478

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.1

9.7

172

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

13.4

9.7

KAC10

NOMESCO Finland

Total nephrectomy with capsule

55.2

9.6

JFB30

NOMESCO Finland

Right hemicolectomy

6.8

9.6

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

9.6

852

6954

TK800

NOMESCO Finland

Hemodialysis

2.7

9.6

231

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

9.6

361

2539

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

4.3

9.6

ZXC96

NOMESCO Finland

Robot assisted procedure

5.7

9.5

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

9.5

223

1402

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.5

9.4

EP3AT

NOMESCO Finland

Neck soft tissue biopsy with ultrasound guidance

100.3

9.4

HA1CM

NOMESCO Finland

Mammary gland extensive MRI examination with 3 Tesla magnet

100.3

9.4

OAA41

NOMESCO Finland

Health check based on individual needs

100.3

9.4

WE300

NOMESCO Finland

Profylactive therapy of malignancy with biomoidiers

100.3

9.4

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

100.3

9.4

B59

ICD-10 Finland

Pneumocystosis

30.1

9.4

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

17.6

9.4

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

9.4

9670/3-C77.3

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of axilla or arm

+∞

9.4

189

Kela drug reimbursment

Imatinib

+∞

9.4

C07.70

ICD-10 Finland

Malignant tumor of the superficial part of the parotid gland

+∞

9.4

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

9.4

R84

ICPC

Malignant neoplasm bronchus/lung

+∞

9.4

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

9.4

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

9.4

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

9.4

1XC12

NOMESCO Finland

+∞

9.4

C83.41

ICD-10 Finland

Immunoblastic (diffuse)

+∞

9.4

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

21.7

9.3

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

21.7

9.3

L03AA04

ATC

21.7

9.3

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.8

9.3

168

974

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

10.7

9.3

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

6.0

9.2

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

4.7

9.2

R06.0

ICD-10 Finland

Dyspnoea

1.4

9.1

602

4686

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

7.7

9.1

B74

ICPC

Malignant neoplasm blood other

15.6

9.0

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

9.0

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

36.8

9.0

A07AA09

ATC

vancomycin; oral

3.3

9.0

131

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.5

9.0

265

7842A

ICD-9 Finland

Symptoms involving head and neck, Swelling, mass, or lump in head and neck

18.6

8.9

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

8.9

265

1767

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.1

8.9

457

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.8

8.8

189

GD6AD

NOMESCO Finland

CT of chest and neck

14.1

8.7

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

50.1

8.7

XKD00

NOMESCO Finland

Uroflowmetry

1.5

8.6

352

2515

B03XA02

ATC

darbepoetin alfa; parenteral

3.0

8.6

159

KAD00

NOMESCO Finland

Partial nephrectomy

16.3

8.5

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

27.6

8.5

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.9

8.5

177

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.1

8.4

J94.0

ICD-10 Finland

Chylous effusion

90.3

8.4

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

90.3

8.4

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

90.3

8.4

WW302

NOMESCO Finland

Allogenic transfer of stem cells from relative

90.3

8.4

L02BX02

ATC

degarelix; parenteral

+∞

8.3

9651/3-C77.8

ICD-O-3

Hodgkin lymphoma, lymphocyte-rich of lymph nodes of multiple regions

+∞

8.3

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

8.3

C80

ICD-10 Finland

Malignant neoplasm, without specification of site

+∞

8.3

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

+∞

8.3

C44.3

ICD-10 Finland

Malignant neoplasm: Skin of other and unspecified parts of face

+∞

8.3

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

8.3

399

Kela drug reimbursment

Venetoclax

+∞

8.3

Z08.2

ICD-10 Finland

Follow-up examination after chemotherapy for malignant neoplasm

+∞

8.3

L01XE01

ATC

[U] imatinib; oral

+∞

8.3

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

8.3

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

8.3

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

8.3

C83.52

ICD-10 Finland

T-lymphoblastic lymphoma or leukemia

+∞

8.3

9695/3-C77.2

ICD-O-3

Follicular lymphoma, grade 1 of intra-abdominal lymph nodes

+∞

8.3

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

+∞

8.3

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

8.3

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

8.3

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

8.3

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

+∞

8.3

C83.4

ICD-10 Finland

Immunoblastic (diffuse) non-Hodgkin's lymphoma

+∞

8.3

C83.7

ICD-10 Finland

Burkitt lymphoma

+∞

8.3

C80.0

ICD-10 Finland

Malignant neoplasm, primary site unknown, so stated

+∞

8.3

2002A

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Burkitt's tumour or lymphoma

+∞

8.3

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

8.3

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

+∞

8.3

L02BB04

ATC

enzalutamide; oral

+∞

8.3

C16.00

ICD-10 Finland

Cardia

+∞

8.3

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

8.3

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

2.4

8.3

271

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

8.5

8.3

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

7.1

8.2

A02BA02

ATC

ranitidine; systemic

1.4

8.2

483

3686

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

8.2

202

1288

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

8.1

178

1099

D11.70

ICD-10 Finland

Gland sublingual

7.5

8.1

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

8.1

406

3011

K52.0

ICD-10 Finland

Gastroenteritis and colitis due to radiation

33.4

8.1

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

33.4

8.1

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

6.8

8.1

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

8.1

814

6732

N02AA01

ATC

morphine; systemic, rectal

4.5

8.0

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

8.9

8.0

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

8.9

8.0

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.4

8.0

274

I50.1

ICD-10 Finland

Left ventricular failure

1.8

8.0

137

788

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

3.0

8.0

150

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.6

7.9

214

WW200

SPAT

0.6

7.9

1640

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.5

7.9

955

A02BX02

ATC

sucralfate; oral

2.0

7.9

511

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.6

7.7

DAB10

NOMESCO Finland

Partial excision of auricle

45.1

7.7

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.6

7.6

9109

FHL

Other measure in this category

8.0

7.6

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

6.7

7.6

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.8

7.6

167

ZZA50

NOMESCO Finland

Full thickness skin graft

11.9

7.6

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

11.9

7.6

ZX100

NOMESCO Finland

Oral

3.4

7.5

101

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.4

7.5

266

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.8

7.5

114

631

JDD00

NOMESCO Finland

Total gastrectomy and Roux-en-Y oesophagojejunostomy

80.3

7.4

JN6CD

NOMESCO Finland

Very extensive CT of torso and neck

80.3

7.4

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

80.3

7.4

ZX131

NOMESCO Finland

Intrathecal

80.3

7.4

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

80.3

7.4

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

3.3

7.4

108

9650/3-C77.3

ICD-O-3

Hodgkin lymphoma, NOS, of lymph nodes of axilla or arm

+∞

7.3

9823/3-C77.0

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of head, face and neck

+∞

7.3

9687/3-C77.9

ICD-O-3

Burkitt lymphoma, NOS, of lymph node, NOS

+∞

7.3

9688/3-C77.8

ICD-O-3

T-cell/histiocyte rich large B-cell lymphoma of lymph nodes of multiple regions

+∞

7.3

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

7.3

9688/3-C77.9

ICD-O-3

T-cell/histiocyte rich large B-cell lymphoma of lymph node, NOS

+∞

7.3

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

7.3

9705/3-C77.8

ICD-O-3

Angioimmunoblastic T-cell lymphoma of lymph nodes of multiple regions

+∞

7.3

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

7.3

YN1AD

NOMESCO Finland

CT examination of extremities for dose design of radiotherapy

+∞

7.3

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

7.3

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

7.3

L01XX52

ATC

venetoclax; oral

+∞

7.3

JM2AT

NOMESCO Finland

Biopsy of spleen with ultrasound guidance

+∞

7.3

9659/3-C77.4

ICD-O-3

Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of inguinal region or leg

+∞

7.3

1DB01

NOMESCO Finland

+∞

7.3

9691/3-C77.2

ICD-O-3

Follicular lymphoma, grade 2 of intra-abdominal lymph nodes

+∞

7.3

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

7.3

8130/3-C67.9

ICD-O-3

Papillary urothelial carcinoma of bladder, NOS

+∞

7.3

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

+∞

7.3

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

+∞

7.3

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

7.3

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

7.3

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

7.3

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

7.3

C85

ICD-10 Finland

Other and unspecified types of non-Hodgkin lymphoma

+∞

7.3

EL4AT

NOMESCO Finland

Salivary gland cytology with ultrasound guidance

6.8

7.3

KA3EB

NOMESCO Finland

Antegrade pyelography

6.8

7.3

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

3.5

7.3

B04

ICPC

Blood symptom/complaint

5.8

7.2

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

7.3

7.2

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

7.2

249

1719

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

7.1

274

1931

BA2AT

NOMESCO Finland

Biopsy of thyroid with ultrasound quidance

30.1

7.1

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

30.1

7.1

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

20.1

7.1

L04AA06

ATC

mycophenolic acid; systemic

2.8

7.1

156

Z10.8

ICD-10 Finland

Routine general health check-up of other defined subpopulations

2.3

7.1

272

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.5

7.0

206

ZX114

NOMESCO Finland

Intramuscular

3.0

7.0

129

C07AB07

ATC

bisoprolol; oral

1.2

7.0

1219

10715

RS221

NOMESCO Finland

3.1

7.0

118

WX704

NOMESCO Finland

Intubation

1.7

7.0

140

845

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

2.0

7.0

418

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.8

6.9

105

581

L04AD01

ATC

ciclosporin; systemic

2.6

6.9

187

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.9

6.9

479

WX199

NOMESCO Finland

Other local analgesia

2.3

6.9

272

L04AA01

ATC

[U] ciclosporin; systemic

2.8

6.8

142

EP1BG

NOMESCO Finland

MRI examination of soft tissue of neck with high intesity magnet

8.3

6.8

ZZR10

NOMESCO Finland

Flap of skin and muscle

10.9

6.8

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

6.8

536

4274

J70.4

ICD-10 Finland

Drug-induced interstitial lung disorders, unspecified

40.1

6.8

D36.0

ICD-10 Finland

Benign neoplasm: Lymph nodes

40.1

6.8

D75

ICPC

Malignant neoplasm colon/rectum

40.1

6.8

L02AE04

ATC

triptorelin; parenteral

40.1

6.8

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

40.1

6.8

23999

ICD-8 Finland

Neoplasm of unspecified nature of other and unspecified organs, Other and unspecified sites

16.7

6.7

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.7

6.7

124

731

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

2.8

6.6

139

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

6.6

606

4926

SPAT1255

SPAT

Intravenous administration of medicine

1.6

6.6

146

906

D06BB10

ATC

imiquimod; topical

2.0

6.6

409

0388X

ICD-9 Finland

Septicaemia, Other specified septicaemias

10.0

6.5

R22.7

ICD-10 Finland

Localized swelling, mass and lump, multiple sites

10.0

6.5

I88.8

ICD-10 Finland

Other nonspecific lymphadenitis

10.0

6.5

R93.8

ICD-10 Finland

Abnormal findings on diagnostic imaging of other specified body structures

6.2

6.5

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

70.0

6.4

A21

ICPC

Risk factor for malignancy

70.0

6.4

D73.0

ICD-10 Finland

Hyposplenism

70.0

6.4

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

70.0

6.4

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.6

6.4

155

988

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

4.9

6.3

N06DX01

ATC

memantine; oral

0.5

6.3

1075

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

11.0

6.3

Z31.8

ICD-10 Finland

Other procreative management

18.0

6.3

2014X

ICD-9 Finland

Hodgkin's disease, Lymphocytic-histiocytic predominance[MORBUS HODGKIN,LYMPHOCYTIC PREDOMINANCE"""",NUD]

+∞

6.2

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

+∞

6.2

9673/3-C77.4

ICD-O-3

Mantle cell lymphoma of lymph nodes of inguinal region or leg

+∞

6.2

V03AB28

ATC

+∞

6.2

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

6.2

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

6.2

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

6.2

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

+∞

6.2

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

+∞

6.2

C38.3

ICD-10 Finland

Malignant neoplasm: Mediastinum, part unspecified

+∞

6.2

2017X

ICD-9 Finland

Hodgkin's disease, Lymphocytic depletion[MORBUS HODGKIN, LYMPHOCYTIC DEPLETION NUD]

+∞

6.2

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

+∞

6.2

L01EA01

ATC

imatinib; oral (bcr-abl tyrosine kinase inhibitors)

+∞

6.2

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

6.2

20018

ICD-8 Finland

Lymphosarcoma and reticulum-cell sarcoma, Lymphosarcoma loco non indicato sive generalisatum

+∞

6.2

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

6.2

9680/3-C80.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of unknown primary site

+∞

6.2

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

6.2

XX1XN

NOMESCO Finland

Other isotope examination

+∞

6.2

9698/3-C77.4

ICD-O-3

Follicular lymphoma, grade 3 of lymph nodes of inguinal region or leg

+∞

6.2

5609

FHL

Other measure in this category

+∞

6.2

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

+∞

6.2

C90.2

ICD-10 Finland

Extramedullary plasmacytoma

+∞

6.2

C44.01

ICD-10 Finland

Basocellular carcinoma of the lip skin

+∞

6.2

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

6.2

C779, 9715, 3

ICD-O-3

+∞

6.2

L01XB01

ATC

procarbazine; oral

+∞

6.2

4CJ01

NOMESCO Finland

+∞

6.2

9673/3-C77.0

ICD-O-3

Mantle cell lymphoma of lymph nodes of head, face and neck

+∞

6.2

9670/3-C77.4

ICD-O-3

Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of inguinal region or leg

+∞

6.2

WE100

NOMESCO Finland

Profylactic cytostatic therapy

+∞

6.2

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

+∞

6.2

3AF07

NOMESCO Finland

+∞

6.2

JL2AT

NOMESCO Finland

Cytology of pancreas with ultrasound guidance

+∞

6.2

9690/3-C77.3

ICD-O-3

Follicular lymphoma, NOS, of lymph nodes of axilla or arm

+∞

6.2

C38.1

ICD-10 Finland

Malignant neoplasm: Anterior mediastinum

+∞

6.2

C43.99

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin other or unspecified histology

+∞

6.2

L01CA04

ATC

vinorelbine; systemic

+∞

6.2

20228

ICD-8 Finland

Other neoplasms of lymphoid tissue, Other primary malignant neoplasms of lymphoid tissue

+∞

6.2

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

6.2

XQ848

NOMESCO Finland

Dermatological photography

2.4

6.2

219

WX1DG

NOMESCO Finland

Very extensive total body MRI with high intensity magnet

26.7

6.2

B44.0

ICD-10 Finland

Invasive pulmonary aspergillosis

26.7

6.2

GA2AT

NOMESCO Finland

Pleural biopsy with ultrasound guidance

26.7

6.2

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

4.8

6.2

TQW80

NOMESCO Finland

Local dermatologic skincare

2.2

6.2

252

P20

ICPC

Memory disturbance

0.7

6.2

155

2266

R18

ICD-10 Finland

Ascites

2.9

6.2

118

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

4.5

6.1

M05BX04

ATC

denosumab; parenteral

1.9

6.1

413

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.8

6.1

129

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

6.1

365

2789

N06DA03

ATC

rivastigmine; oral, transdermal

0.4

6.1

592

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.9

6.1

C09AA05

ATC

ramipril; oral

1.3

6.0

624

5151

D46.7

ICD-10 Finland

Other myelodysplastic syndromes

10.0

6.0

A46

ICD-10 Finland

Erysipelas

1.4

6.0

319

2390

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3651

21452

2.78

317.05

9.0

5.5

mmol/l

1.2

2.45

3505

18995

(3013115) Eosinophils [#/volume] in Blood

4257

24305

3.56

307.65

8.8

5.6

e9/l

0.2

18.07

3921

21154

(3013650) Neutrophils [#/volume] in Blood by Automated count

5004

25720

6.56

307.65

23.3

6.5

e9/l

3.8

4.3

45.74

4740

22051

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1715

4856

4.54

307.65

1.5

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1650

4117

5.14

307.65

1.5

1.6

—

(3002030) Lymphocytes/100 leukocytes in Blood

4118

22328

3.66

307.65

8.8

5.8

25.2

27.5

24.65

3962

20525

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

559

692

8.80

307.65

4.8

5.9

iu/ml

346.0

766.2

0.74

101

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

293

192

15.99

307.65

2.9

2.2

e9/l

0.2

0.21

252

171

(3019198) Lymphocytes [#/volume] in Blood

4223

24021

3.53

307.65

8.5

5.5

e9/l

1.8

1.9

0.20

3921

20958

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3860

20560

3.44

307.65

6.1

3.7

—

(1175426) CD3 cells/100 lymphocytes in Blood

375

213

18.71

307.65

2.3

2.0

73.1

72.0

0.39

358

201

(3017181) Myelocytes/100 leukocytes in Blood

1259

3798

3.93

307.65

4.6

3.8

1.1

0.8

4.64

716

830

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

495

526

10.16

307.65

2.6

2.9

u/ml

9099.3

625.1

1.07

(3004809) Band form neutrophils/100 leukocytes in Blood

475

583

8.76

307.65

3.4

2.9

1.8

1.2

2.14

370

441

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

373

208

19.05

307.65

2.3

2.0

14.4

16.0

0.57

155

(3015377) Calcium [Moles/volume] in Serum or Plasma

3054

14778

3.16

307.65

7.5

2.1

mmol/l

2.3

2.4

0.42

2862

12345

(3011412) CD3 cells [#/volume] in Blood

476

273

18.84

307.65

2.6

2.2

e9/l

1.0

0.09

313

159

(3019069) Monocytes/100 leukocytes in Blood

4093

21802

3.73

307.65

8.9

6.0

9.2

8.8

14.36

3954

20157

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4889

23120

6.89

307.65

17.0

3.9

umol/l

10.1

12.0

21.95

4827

21608

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1570

2517

8.08

307.65

5.1

1.5

ug/l

24.8

8.6

1.72

1343

1886

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

372

197

20.06

307.65

2.3

2.0

—

(3022096) Basophils/100 leukocytes in Blood

4016

21053

3.72

307.65

8.5

5.7

0.6

0.7

3.50

3875

19395

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4248

23773

3.66

307.65

10.8

5.9

mmol/l

1.2

2.17

3585

19942

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

339

255

14.03

307.65

2.4

1.3

ug/l

20.6

19.0

0.25

333

248

(4035726)

2063

1441

21.24

307.65

1.7

1.2

—

(40765096) Chromosome analysis panel by Banding

278

44.79

307.65

1.2

1.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5337

36398

5.06

307.65

20.3

5.5

u/l

88.5

75.9

44.74

5252

33689

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

301

201

15.71

307.65

2.8

2.2

e6/l

545.7

432.8

2.11

251

172

(3042111) Morphology [Interpretation] in Bone marrow Narrative

573

609

10.29

307.65

1.5

1.3

—

(3006504) Eosinophils/100 leukocytes in Blood

4082

21675

3.74

307.65

8.6

5.7

2.7

3.0

10.82

3938

19948

(40768795) Lymph node Pathology biopsy report

981

119.36

307.65

1.4

1.1

—

(3018010) Neutrophils/100 leukocytes in Blood

4027

22108

3.47

307.65

8.3

5.6

58.5

57.6

3.86

3884

20428

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1445

2569

7.08

307.65

1.4

—

(42870588) Differential panel, method unspecified - Blood

3213

15692

3.24

307.65

8.4

5.5

—

(3001604) Monocytes [#/volume] in Blood

4178

23346

3.57

307.65

8.3

5.5

e9/l

0.6

1.40

3837

19983

(3024561) Albumin [Mass/volume] in Serum or Plasma

4066

19844

4.22

307.65

7.7

3.9

g/l

33.8

35.6

69.88

3936

18125

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

731

631

13.05

307.65

1.3

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

625

112.35

307.65

1.4

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

341

243

14.81

307.65

2.3

2.2

29.9

46.1

3.68

(3045142) Bone marrow Pathology biopsy report

586

342

18.87

307.65

1.5

1.2

—

(40768804) Tissue Pathology biopsy report

2977

15358

2.85

307.65

2.8

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

2802

13482

3.01

307.65

3.6

2.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1134

3138

4.22

307.65

3.5

2.3

g/l

8.8

10.8

36.96

1084

2861

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2302

6978

4.72

307.65

6.3

2.7

mmol/l

0.8

22.50

2236

6403

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2796

4718

10.19

307.65

7.3

2.8

u/l

260.8

236.8

8.85

2715

4368

(46235355) HIV 1 and 2 tests - Meaningful Use set

1817

5894

3.98

307.65

1.6

1.7

—

(3023368) Bacteria identified in Blood by Culture

3018

12684

3.76

307.65

6.5

3.9

—

(3006315) Basophils [#/volume] in Blood

4192

23490

3.58

307.65

8.3

5.5

e9/l

0.0

10.95

3859

20136

(3032080) INR in Blood by Coagulation assay

3459

20032

2.70

304.81

9.7

10.3

inr

1.2

1.3

11.05

992

5602

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

780

1866

4.65

302.09

2.1

1.9

ug/l

2.3

1.6

0.66

716

1620

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

531

912

6.29

298.47

3.4

1.9

u/ml

347.1

98.3

1.99

442

737

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

283

221

13.39

295.94

2.9

2.3

e6/l

405.6

715.1

6.19

125

(3021440) Promyelocytes/100 leukocytes in Blood

1140

3656

3.61

293.94

4.7

3.8

0.2

0.1

3.83

654

771

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

253

169

15.58

288.99

3.5

2.5

35.8

41.5

1.76

104

(3002256) Pathology report gross observation

1146

3817

3.47

277.51

1.4

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2102

9901

2.72

274.47

6.8

4.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1075

3483

3.54

271.39

4.5

3.6

0.8

0.5

2.60

464

612

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

523

976

5.77

269.16

2.0

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

456

754

6.46

265.67

1.4

1.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

205

108

19.61

263.04

2.2

2.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

508

944

5.78

262.50

2.0

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

188

22.80

257.40

2.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1750

7740

2.78

255.71

2.4

1.8

—

(3042936) Bacteria identified in Isolate by Culture

1544

6545

2.83

243.23

2.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

375

554

7.15

242.94

4.0

2.0

u/ml

638.2

290.0

0.54

337

503

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

409

670

6.48

240.13

2.1

1.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1454

6041

2.85

237.25

6.4

5.8

mmol/l

1.0

0.36

1407

5561

(3013826) Glucose [Moles/volume] in Serum or Plasma

4217

28760

2.55

236.95

6.7

4.5

mmol/l

6.7

6.8

3.40

4090

26794

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

407

681

6.34

233.91

1.4

1.5

u/ml

113.9

120.3

0.22

100

138

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1785

8323

2.63

231.39

5.6

2.1

mmol/l

2.5

2.4

20.94

1703

7113

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

570

1328

4.64

226.17

7.6

1.5

u/ml

97.1

27.7

6.44

561

1262

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2050

10334

2.49

224.19

3.5

2.1

—

(3018418) pH of Serum or Plasma

2486

13677

2.39

223.54

6.9

3.4

7.4

0.22

675

2415

(3027945) Reticulocytes/100 erythrocytes in Blood

1336

5496

2.84

220.43

3.3

2.2

1.7

0.39

1228

4791

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

223

191

12.09

219.85

1.7

1.3

mg/l

3.5

4.4

1.35

215

184

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1011

3587

3.18

217.15

2.4

2.1

g/l

0.2

1.46

955

3254

(3028026) IgM [Mass/volume] in Serum or Plasma

808

2494

3.59

217.12

2.7

1.5

g/l

1.2

0.07

755

2260

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

928

3176

3.27

211.36

2.0

1.6

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

156

21.91

210.44

3.0

1.4

u/l

43.2

37.3

0.10

151

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

193

143

13.91

207.74

3.2

2.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

600

1553

4.18

207.22

2.4

2.9

—

(3025159) Blasts/100 leukocytes in Blood

971

3482

3.13

203.99

4.7

3.9

0.1

0.3

0.77

499

668

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

171

105

16.73

203.71

2.3

1.9

36.4

26.2

7.63

156

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

106

89.90

201.93

1.2

—

(3006245) CD3-CD19+ cells/100 cells in Blood

171

107

16.42

201.76

2.3

2.2

7.7

8.6

0.40

149

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

247

283

9.06

198.13

1.5

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2387

13448

2.28

197.04

5.1

2.5

umol/l

2254.6

5456.4

5.11

2258

11473

(40758558) Short blood count panel - Blood

2047

10840

2.35

195.30

16.6

4.8

—

(3023520) Reticulocytes [#/volume] in Blood

1048

4134

2.86

184.30

3.6

2.2

e9/l

68.6

69.2

0.20

859

3166

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

408

864

4.99

180.96

1.4

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

118

30.84

180.31

9.1

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

988

3819

2.90

180.15

6.7

3.0

mmol/l

1.2

3.58

964

3229

(40768793) Breast Pathology biopsy report

224

256

9.05

179.93

1.5

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2540

15098

2.18

179.37

3.9

2.3

u/l

54.5

59.7

4.21

2425

13814

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

427

965

4.69

175.02

1.6

—

(3003694) ABO and Rh group [Type] in Blood

2100

11775

2.20

169.76

1.5

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

371

768

5.08

168.81

1.6

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

265

407

6.76

164.97

3.8

3.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

316

582

5.67

163.76

1.6

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

254

388

6.79

158.89

3.6

2.8

56.7

59.7

0.85

157

252

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

351

747

4.93

154.43

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

248

382

6.73

153.89

2.2

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

257

418

6.38

151.26

2.1

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

329

677

5.08

150.54

1.7

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

311

612

5.30

149.74

1.6

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

424

1076

4.16

149.28

1.3

—

(3000060) B lymphocytes [#/volume] in Blood

120

17.47

146.44

2.2

e6/l

99.8

146.5

0.84

(3021589) Normoblasts [#/volume] in Blood

3090

20807

2.00

146.06

17.7

8.6

e9/l

0.0

0.91

2709

17014

(3026008) Bacteria identified in Urine by Culture

2290

13957

2.03

142.91

3.5

3.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

288

567

5.28

138.49

1.8

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

942

4035

2.58

138.00

3.3

1.6

g/l

64.6

66.8

13.21

900

3588

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

320

698

4.79

136.51

1.3

u/ml

285.7

279.8

0.12

200

443

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1144

5399

2.38

135.62

2.2

1.7

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

126

13.52

134.03

3.4

2.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1139

5397

2.37

133.62

2.2

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

719

2767

2.81

129.79

1.7

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

215

343

6.46

128.85

2.2

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

215

343

6.46

128.85

2.2

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

215

343

6.46

128.85

2.2

1.3

—

(3002582) Erythrocytes [#/volume] in Urine

2274

14307

1.95

125.50

3.5

3.1

e6/l

120.2

83.8

0.30

1912

10883

(3031040) Bacteria [#/volume] in Urine by Automated count

4103

31381

1.96

123.88

5.2

4.3

e6/l

372.2

2004.2

3.71

112

463

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

237

440

5.57

121.49

1.8

1.5

—

(3012544) pH of Venous blood

1036

4915

2.34

120.08

4.2

3.9

7.4

—

(3020779) Urea [Moles/volume] in Serum or Plasma

943

4316

2.40

118.50

7.0

7.4

mmol/l

9.4

10.7

5.85

911

4086

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2298

14737

1.90

117.86

7.1

2.7

u/l

34.2

0.01

2220

13854

(3002032) Base excess in Venous blood by calculation

1002

4721

2.35

117.83

4.2

3.9

mmol/l

2.2

1.9

2.40

815

3849

(3033658) Prothrombin time (PT) actual/Normal

1877

11274

1.97

117.02

5.3

3.6

89.1

87.1

3.08

1850

10970

(3036481) Cortisol [Moles/volume] in Serum or Plasma

872

3900

2.44

115.11

4.6

1.8

nmol/l

386.6

367.7

2.11

839

3517

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

150

183

8.38

114.18

2.5

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

150

183

8.38

114.18

2.5

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

150

183

8.38

114.18

2.5

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

150

183

8.38

114.18

2.5

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

221

413

5.52

112.44

1.6

1.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

991

4737

2.31

112.25

4.2

3.8

kpa

5.8

1.53

974

4599

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

130

137

9.68

110.86

2.6

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

351

964

3.80

110.18

1.7

1.4

u/l

15.2

8.8

9.36

289

771

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1380

7576

2.07

109.85

2.5

1.9

29.6

30.0

1.66

1344

7340

(3042631) Mycobacterium sp identified in Specimen

269

614

4.54

108.29

2.1

3.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

128

138

9.45

107.31

2.7

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

128

138

9.45

107.31

2.7

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

194

340

5.86

105.66

2.5

2.4

—

(3026782) Osmolality of Urine

1565

9112

1.97

104.88

3.1

2.6

mosm/kgh2o

556.6

555.6

0.07

1426

7617

(3014576) Chloride [Moles/volume] in Serum or Plasma

1140

5916

2.14

104.80

7.6

6.9

mmol/l

104.0

104.3

1.43

1106

5773

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

534

1960

2.89

104.46

2.6

1.8

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

638

2570

2.66

104.39

2.7

2.6

e6/l

0.4

0.3

1.14

628

2512

(3037692) Legionella sp identified in Specimen by Organism specific culture

127

141

9.18

104.13

1.2

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

985

4860

2.23

102.66

4.4

2.3

umol/l

10.0

8.1

1.38

888

4183

(3032352) Blasts [#/volume] in Cerebral spinal fluid

31.77

101.73

1.8

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

186

327

5.84

100.96

1.3

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

239

525

4.70

100.85

1.6

1.5

g/l

33.7

29.2

5.63

225

460

(3018095) Leukocytes [#/volume] in Urine

2464

16756

1.80

100.17

4.1

3.5

e6/l

157.3

102.5

0.91

1994

11758

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

129

156

8.43

98.88

9.1

1.1

u/ml

79.5

133.4

0.37

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

371

1149

3.38

96.90

3.9

3.1

mg/l

1.3

1.7

11.41

356

1018

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

107

106

10.26

95.38

1.2

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

156

245

6.51

94.84

1.2

1.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2325

15755

1.77

94.03

3.4

3.1

ng/l

1561.6

1461.1

0.54

2104

13548

(40758292) HTLV I+II Ab panel - Serum

21.45

93.81

1.5

1.3

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

113

127

9.05

91.76

1.8

2.2

u/ml

32141.0

91681.9

0.36

(3023199) Leukocytes [#/volume] in Pleural fluid

214

471

4.67

90.04

1.6

1.5

e6/l

1592.4

2974.8

1.35

162

348

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

479

1799

2.81

89.39

2.1

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

748

3478

2.31

89.06

2.0

1.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

607

2589

2.50

87.62

3.6

3.3

mmol/l

25.3

25.2

0.30

598

2497

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

388

1314

3.09

87.25

1.7

—

(3019225) pH of Specimen

944

4871

2.11

86.64

7.3

3.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5466

48343

2.40

86.62

32.5

13.2

mg/l

29.0

23.8

23.88

5109

37742

(40768806) Pleura Pathology biopsy report

182

361

5.17

86.58

1.6

1.5

—

(44790047)

211

476

4.56

86.10

1.7

1.4

—

(44790049)

211

476

4.56

86.10

1.7

1.4

—

(44806118)

211

476

4.56

86.10

1.7

1.4

—

(44790048)

211

476

4.56

86.10

1.7

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

154

264

5.96

85.78

1.8

1.3

—

(3013707) Erythrocyte sedimentation rate by Westergren method

4417

36365

1.80

85.51

5.5

4.1

mm/h

16.8

12.0

51.61

4171

33450

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

420

1506

2.92

85.32

3.1

3.2

u/ml

0.4

0.3

1.41

264

879

(3037467) Urinalysis macro (dipstick) panel - Urine

4127

33346

1.75

84.93

5.5

4.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

194

415

4.80

84.48

1.5

e6/l

37802.4

61222.4

0.49

120

242

(3000850) Epithelial cells [#/volume] in Urine

1598

9958

1.82

83.76

2.8

2.5

e6/l

5.3

4.9

0.65

1465

8603

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

206

466

4.54

83.76

1.2

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

380

1302

3.05

83.68

1.4

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

139

222

6.39

83.12

1.8

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

182

381

4.89

81.32

1.3

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

137

221

6.32

81.13

1.9

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

1971

13163

1.74

80.93

3.5

3.0

e6/l

0.6

0.4

0.53

1615

9805

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

168

330

5.21

80.80

1.9

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2708

19867

1.66

77.13

4.5

3.8

ng/l

40.9

71.5

1.73

2243

14241

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

272

799

3.52

76.98

5.3

3.6

57.6

58.3

0.31

272

799

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

173

366

4.84

76.33

1.5

1.4

u/l

33.9

28.6

1.06

163

272

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1196

6987

1.89

76.07

2.2

2.6

g/l

2.2

2.3

9.01

1123

6418

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1131

6506

1.91

75.36

2.3

2.7

21.2

22.8

3.07

976

5447

(3013512) EKG study

2151

15022

1.67

73.06

5.1

4.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

123

200

6.26

72.26

1.7

1.2

ug/l

3.0

2.9

0.05

171

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

497

2123

2.46

71.02

5.4

5.1

1.6

1.7

0.55

465

1988

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

221

598

3.80

70.63

5.2

6.5

mg/l

11.1

11.9

1.26

205

542

(3007930) Methemoglobin/Hemoglobin.total in Blood

490

2097

2.45

69.70

5.6

5.2

0.9

0.58

461

1965

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

17.43

69.60

1.3

1.2

—

(40768800) Prostate Pathology biopsy report

165

365

4.62

68.96

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

330

1163

2.94

68.95

2.6

2.4

g/l

4.0

3.6

4.09

320

1095

(3000991) Gas panel - Venous blood

759

3912

2.08

68.80

7.2

8.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1248

7611

1.81

68.26

2.3

2.6

umol/l

11.6

13.1

10.23

1173

6987

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

23.03

66.13

2.0

1.0

ug/l

14.8

1.6

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

119.74

65.97

1.1

1.0

—

(3012441) Differential panel - Pleural fluid

168

392

4.38

65.66

1.6

1.5

—

(3003396) Base excess in Arterial blood by calculation

971

5536

1.90

65.63

7.0

7.4

mmol/l

1.5

1.2

1.74

782

4274

(3016502) Oxygen saturation in Arterial blood

903

5034

1.93

65.30

7.1

7.8

95.7

95.2

1.50

868

4834

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

878

4856

1.95

64.98

5.0

3.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

225

653

3.54

64.82

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

11.94

64.33

1.1

1.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

156

351

4.54

63.84

1.4

1.3

u/l

362.2

311.2

0.46

146

332

(3017446) Testosterone [Moles/volume] in Serum or Plasma

658

3319

2.10

62.88

2.3

2.2

nmol/l

8.5

14.6

49.38

587

2897

(3027801) Oxygen [Partial pressure] in Arterial blood

964

5561

1.87

62.57

7.0

7.4

kpa

12.5

11.7

4.75

915

5288

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

212

606

3.59

62.49

1.5

1.4

pmol/l

227.5

73.0

4.57

207

588

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

964

5565

1.87

62.42

7.0

7.4

kpa

5.1

0.02

911

5302

(3007853) Bacteria identified in Skin by Aerobe culture

960

5575

1.86

60.87

1.8

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

823

4547

1.94

60.82

7.5

8.3

g/l

115.4

123.1

20.20

789

4368

(36304419) Bacteria [Presence] in Urine

1825

12674

1.63

60.79

3.4

2.9

—

(1761482) Bacteria [#/volume] in Urine by Culture

346

1353

2.65

59.24

4.7

4.0

—

(3047181) Lactate [Moles/volume] in Blood

378

1547

2.54

58.96

6.5

6.3

mmol/l

1.4

1.3

1.15

335

1362

(3024354) Oxygen [Partial pressure] in Venous blood

731

3952

1.97

57.38

3.7

3.2

kpa

4.5

4.6

0.18

714

3820

(3045788) Cell count panel - Pleural fluid

151

363

4.24

56.78

1.6

—

(3028433) Virus identified in Specimen by Culture

145

6.43

55.75

1.4

1.1

—

(3009343) pH of Capillary blood

617

3174

2.05

55.63

4.2

3.6

7.4

1.18

376

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

623

3219

2.04

55.49

4.2

3.6

kpa

5.1

0.82

582

2950

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1172

7402

1.72

55.39

3.2

2.8

e6/l

2.2

2.4

0.37

754

4015

(1617658) Protocol used for examination of sentinel lymph nodes

119.17

54.87

1.0

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

621

3218

2.04

54.85

3.6

3.4

g/l

119.7

130.9

28.09

608

3130

(3008152) Bicarbonate [Moles/volume] in Arterial blood

628

3276

2.02

54.43

7.6

7.3

mmol/l

25.0

24.6

2.06

587

3036

(3037756) Immunofixation for Serum or Plasma

267

955

2.88

54.20

1.4

1.2

—

(3019060) Gas panel - Arterial blood

644

3410

1.99

53.48

5.6

5.0

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1750

12333

1.59

53.44

2.0

2.3

mg/l

3.4

2.9

7.94

1535

10490

(3036782) Glucose [Moles/volume] in Pleural fluid

144

350

4.19

53.38

1.4

mmol/l

6.2

6.7

1.33

132

316

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

11.32

52.63

1.5

1.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

470

2257

2.17

50.62

1.7

1.6

g/l

1.8

1.5

3.66

394

1926

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

159

432

3.75

50.52

3.1

2.9

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

587

3070

2.01

50.35

4.2

3.5

mmol/l

2.3

1.8

2.39

457

2211

(3000494) Fungus identified in Specimen by Culture

921

5583

1.77

49.82

1.6

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1504

10369

1.60

49.77

1.8

1.7

mg/l

2.0

1.2

7.22

1250

7874

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

218

742

3.01

48.37

4.4

1.9

u/l

1110.7

3944.8

2.32

299

(4281824)

113

248

4.62

47.73

1.1

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

200

653

3.13

47.67

2.4

2.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

177

539

3.35

47.31

2.0

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

177

540

3.35

47.17

2.1

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

177

542

3.33

46.89

2.0

1.3

—

(3035880) pH of Pleural fluid

103

213

4.90

46.73

1.4

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

280

1113

2.59

46.28

1.7

1.3

iu/l

28.5

28.0

0.08

225

950

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

491

2488

2.06

45.82

8.8

10.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

176

545

3.30

45.80

2.1

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

259

998

2.67

45.58

1.8

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4569

50119

0.64

45.56

4.5

5.3

mmol/l

2.7

0.51

4099

46056

(3024522) Salmonella sp identified in Specimen by Organism specific culture

176

550

3.27

45.13

2.1

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

176

5.23

44.59

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

176

5.23

44.59

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

132

344

3.90

44.53

1.7

1.4

nmol/l

0.3

0.48

110

278

(3008536) Aspergillus sp Ab [Presence] in Serum

8.45

44.15

2.7

1.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

177

563

3.21

44.09

2.1

1.3

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

11.30

43.98

2.0

1.4

ng/l

94.8

114.5

0.30

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

197

671

3.00

43.66

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4415

48699

0.65

43.63

4.1

4.7

mmol/l

1.4

11.19

3985

44660

(3007164) IgA [Mass/volume] in Serum or Plasma

1242

8414

1.60

43.37

2.1

1.3

g/l

2.1

2.6

11.24

949

4860

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

111

261

4.31

43.01

1.3

u/l

18.2

11.7

0.95

104

231

(3001893) Eosinophils/100 leukocytes in Pleural fluid

113

6.35

42.65

1.5

1.4

1.2

2.2

0.92

(3014111) Lactate [Moles/volume] in Serum or Plasma

706

4133

1.80

42.56

6.0

7.1

mmol/l

1.5

1.4

0.64

688

3974

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

108

254

4.31

41.84

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1200

8125

1.60

41.81

3.1

2.6

e6/l

1.5

1.1

1.56

780

4706

(3039000) Anion gap in Blood

266

1086

2.52

41.57

7.7

7.3

mmol/l

11.0

11.4

1.11

240

972

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

11.07

41.52

1.3

1.5

81.1

69.2

1.09

(3018572) Chloride [Moles/volume] in Blood

266

1087

2.51

41.49

7.7

7.3

mmol/l

104.8

0.04

240

973

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1426

10089

1.54

40.83

4.2

4.0

ng/l

392.3

577.3

0.61

1143

8193

(3028626) Oxygen [Partial pressure] in Capillary blood

261

1067

2.51

40.67

2.7

3.2

kpa

8.0

0.02

233

984

(3012501) Base excess in Blood by calculation

256

1039

2.53

40.51

4.4

4.0

mmol/l

2.9

2.5

1.46

195

685

(3019550) Sodium [Moles/volume] in Serum or Plasma

5485

50948

1.85

40.42

34.0

15.9

mmol/l

139.1

139.8

61.06

5417

49585

(3041096) Erythrocytes [Presence] in Urine by Automated

1672

12296

1.50

39.67

4.6

3.3

—

(1616796) Gas panel - Central venous blood

252

1027

2.52

39.53

3.8

3.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4481

49069

0.66

39.33

4.1

4.7

mmol/l

4.5

0.00

4053

45306

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

178

4.89

39.01

1.3

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

517

2819

1.91

38.93

1.9

1.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

923

13674

0.62

38.80

1.7

mmol/l

1.5

1.4

3.35

780

11327

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

8.79

38.38

1.9

1.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

5485

51083

1.82

38.16

34.3

16.0

mmol/l

4.0

0.03

5414

49627

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

111

287

3.92

37.90

1.2

1.1

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

460

2458

1.94

36.74

3.0

2.8

1.2

0.35

454

2439

(3015235) Bicarbonate [Moles/volume] in Capillary blood

286

1277

2.30

36.61

2.7

3.4

mmol/l

24.9

24.6

0.34

233

1128

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

450

2399

1.95

36.18

2.8

2.7

0.7

1.86

440

2290

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

141

5.23

35.86

1.5

1.4

61.4

63.9

0.20

117

(40767503) Oxygen content in Capillary blood by calculation

240

1002

2.45

35.75

2.7

2.5

15.3

16.4

3.35

122

532

(3000093) Morphology [Interpretation] in Blood Narrative

140

439

3.24

35.74

1.1

—

(3022313) Gas panel - Capillary blood

438

2335

1.94

35.19

4.6

3.7

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4225

46569

0.69

35.18

6.0

6.3

mmol/mol

40.7

40.5

1.00

3862

42939

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

149

492

3.08

34.89

2.4

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3560

30539

1.40

34.70

4.0

3.0

u/l

67.8

47.9

16.96

3349

28015

(3010421) pH of Blood

274

1231

2.28

34.57

4.3

4.0

7.4

3.55

252

1014

(3021901) Oxygen saturation in Capillary blood

217

882

2.51

34.24

2.7

3.0

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

7.76

33.98

7.6

1.6

u/l

66.4

92.5

0.19

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

271

1227

2.27

33.56

1.9

2.0

mg/l

11.5

11.4

0.07

253

1130

(3025941) Bacteria identified in Stool by Culture

449

2480

1.88

32.34

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

378

1972

1.98

32.30

1.8

1.9

u/l

41.7

38.5

1.86

338

1685

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

216

911

2.42

31.48

1.3

1.2

miu/ml

109.9

212.9

4.06

384

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

8.72

31.00

1.3

1.1

—

(21494434) Karyotype in Bone marrow

117

360

3.29

30.85

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

274

3.66

30.72

1.7

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

100

280

3.61

30.51

1.7

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

735

4740

1.63

30.49

3.1

3.0

ng/l

221.6

216.3

0.12

687

4345

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

444

2490

1.85

30.45

4.0

3.0

pmol/l

4.4

4.5

1.23

412

2167

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

6.02

29.77

1.3

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4970

45730

1.49

29.74

31.6

12.1

ml/min/173m2

79.2

77.9

4.37

4563

36907

(3042010) Triglyceride [Moles/volume] in Pleural fluid

7.55

29.68

1.3

mmol/l

3.0

2.5

0.12

(3049717) Cytology report of Urine Cyto stain

317

1605

2.03

29.46

3.0

1.8

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

5.60

29.21

1.3

1.4

16.1

28.2

2.07

(40761536) Microorganisms panel - Urine sediment

612

3818

1.67

28.86

4.8

3.9

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

7.50

28.82

3.2

6.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

7.50

28.82

1.6

3.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5504

51940

1.69

28.20

23.3

9.3

u/l

25.9

26.2

0.55

5423

49710

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4329

47073

0.71

27.95

3.8

4.2

mmol/l

1.4

1.3

4.88

3904

42798

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

204

3.96

27.92

1.8

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

204

3.96

27.92

1.8

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

496

2956

1.74

27.65

7.9

9.6

0.7

0.43

491

2935

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

409

2319

1.82

27.02

4.9

4.3

mmol/l

24.5

24.2

1.11

380

2065

(3017732) Neutrophils [#/volume] in Blood

529

3238

1.69

26.73

3.5

2.9

e9/l

4.2

4.1

0.25

403

2403

(3022217) INR in Platelet poor plasma by Coagulation assay

1013

7216

1.49

26.62

18.5

28.1

inr

1.2

1.4

8.29

262

991

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2241

18342

1.35

26.38

4.9

3.9

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

355

1965

1.86

25.32

1.9

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

355

1966

1.86

25.28

2.0

1.4

g/l

7.4

0.13

257

1449

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

354

1961

1.86

25.19

2.0

1.4

g/l

3.5

3.9

3.23

254

1392

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

7.95

25.11

1.2

2.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2332

19338

1.34

24.65

2.8

2.9

ug/l

327.3

133.5

23.56

2182

17720

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

487

2983

1.69

24.49

7.9

9.4

1.4

0.11

481

2962

(3023183) Ammonium ion [Moles/volume] in Plasma

213

997

2.18

24.35

2.0

2.7

umol/l

32.5

34.3

0.53

177

855

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

8.04

23.86

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

4331

39356

1.36

23.82

37.9

15.8

14.4

13.7

137.70

4288

38364

(3006184) Hemoglobin [Mass/volume] in Capillary blood

229

1125

2.08

23.12

2.4

2.2

g/l

122.1

131.1

5.50

170

827

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

329

1830

1.84

23.10

2.0

1.4

g/l

8.9

10.4

6.16

285

1524

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

4.98

22.96

1.7

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

291

1560

1.91

22.92

2.4

1.6

mg/l

34.0

38.7

0.46

234

1244

(3034860) Kappa light chains.free [Mass/volume] in Serum

291

1566

1.90

22.65

2.4

1.6

mg/l

52.0

48.1

0.38

237

1254

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

284

1517

1.92

22.61

2.4

1.5

ratio

5.1

2.3

0.73

136

(40763480) Human metapneumovirus Ag [Presence] in Specimen

18.05

22.09

1.7

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

4.88

21.97

1.3

1.2

ug/l

7.0

84.6

1.09

(3037121) Protein [Mass/volume] in Urine

291

1582

1.88

21.96

4.3

2.6

g/l

0.4

0.3

0.07

159

569

(40760888) Immunoglobulin light chains.free panel - Serum

231

1161

2.03

21.93

2.3

1.5

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

21.88

1.0

0.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

352

2032

1.78

21.86

5.1

3.8

mmol/l

25.3

24.8

2.11

332

1855

(3041918) Cholesterol [Moles/volume] in Pleural fluid

5.34

21.79

1.2

mmol/l

1.8

1.4

1.03

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

6.10

21.53

4.9

2.2

—

(3035350) Ketones [Presence] in Urine by Test strip

2760

23746

1.30

21.30

4.5

3.6

estimate

0.0

0.80

673

4083

(3018405) Lactate [Moles/volume] in Arterial blood

325

1847

1.80

21.27

4.1

4.3

mmol/l

1.4

0.09

315

1809

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

592

3938

1.56

21.18

4.8

2.4

ml/min/173m2

66.3

64.4

0.58

269

1497

(3001964) Herpes simplex virus Ag [Presence] in Specimen

123

4.34

21.03

1.3

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

323

1841

1.80

20.94

2.0

1.4

g/l

3.3

3.0

3.43

259

1421

(3000330) Specific gravity of Urine by Test strip

427

2636

1.67

20.79

4.9

3.4

—

(3009261) Glucose [Presence] in Urine by Test strip

2783

24031

1.29

20.64

4.6

3.7

estimate

0.0

0.00

662

4000

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

118

4.35

20.32

8.7

1.2

—

(3013862) HLA-DP [Type]

17.05

20.28

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

142

607

2.37

20.20

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

597

4021

1.54

20.17

2.6

2.3

u/l

34.0

50.0

0.73

517

3409

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

198

972

2.07

20.06

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

198

972

2.07

20.06

1.4

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

292

1644

1.82

19.72

2.3

1.5

g/l

0.7

0.5

0.62

256

1395

(3021601) Nitrite [Presence] in Urine by Test strip

2745

23751

1.29

19.69

6.3

4.9

estimate

0.0

0.80

681

4171

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

152

678

2.27

19.61

1.3

—

(44786800) Granulocytes/100 leukocytes in Body fluid

7.74

19.53

1.4

1.2

28.3

23.4

0.22

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

251

3.14

19.24

2.1

1.5

—

(3000012) Reticulocyte production index

264

3.06

18.92

1.7

1.5

—

(40768441) Liver Pathology biopsy report

204

3.36

18.80

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

148

3.81

18.70

4.4

2.4

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

6.06

18.55

1.3

u/l

40.7

663.1

0.48

(46236302) HLA-C [Type] by High resolution typing

16.04

18.50

1.0

—

(40760409) HLA-A [Type] by High resolution

16.04

18.50

1.0

—

(40763590) HLA-DQ beta [Type]

16.04

18.50

1.0

—

(40760410) HLA-B [Type] by High resolution

16.04

18.50

1.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

264

1470

1.83

18.49

2.1

1.5

g/l

0.0

0.22

247

1328

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

216

1133

1.94

18.20

2.5

2.3

217.3

188.7

4.69

209

1074

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

186

944

2.00

17.25

1.5

1.6

—

(3020891) Body temperature

342

2097

1.67

17.08

5.7

5.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2293

19643

1.27

16.96

2.2

nmol/l

76.7

78.2

1.51

2120

17292

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

5.54

16.93

1.7

1.4

15.6

7.0

0.67

(3029937) Albumin [Presence] in Urine by Test strip

1588

13028

1.30

16.47

4.8

4.1

estimate

0.0

0.16

610

4042

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

239

1346

1.81

16.16

2.1

1.5

g/l

0.0

0.00

225

1226

(3023419) Bacteria identified in Sputum by Culture

140

659

2.15

15.90

1.9

2.4

—

(40758358) Immune stain study

+∞

15.63

1.0

0.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

116

3.90

15.61

3.2

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

10.65

15.53

1.2

2.9

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

240

1372

1.78

15.45

2.1

1.5

g/l

0.0

0.00

225

1232

(3043409) Potassium [Moles/volume] in Arterial blood

269

1589

1.73

15.45

4.6

mmol/l

3.9

0.65

237

1499

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

5.74

15.37

1.7

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

5.74

15.37

1.6

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

5.74

15.37

1.7

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

12.53

15.14

2.3

4.8

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

202

1114

1.84

14.66

3.7

3.6

mg/l

31.8

27.4

0.76

144

724

(3010937) Rubella virus Ab [Presence] in Serum

10.69

14.64

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

385

2532

1.56

14.41

1.4

1.6

—

(3008295) Osmolality of Serum or Plasma

105

458

2.32

14.38

1.2

1.4

mosm/kgh2o

283.2

279.1

1.29

345

(3044290) Cell count panel - Cerebral spinal fluid

174

933

1.89

13.81

1.7

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

256

1548

1.68

13.52

2.1

1.4

g/l

36.2

37.7

3.15

234

1302

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

211

1209

1.77

13.52

1.2

1.3

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

13.03

13.37

1.9

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

369

2.41

13.21

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

359

2380

1.54

12.97

8.6

9.9

mmol/l

24.5

24.4

0.09

335

2184

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

126

3.43

12.45

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

103

3.71

12.34

1.6

1.4

—

(3051651) Icteric interference index of Serum or Plasma

234

2.71

12.16

3.7

4.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

269

2.58

12.11

1.1

—

(3036489) Thrombin time

256

1599

1.63

11.95

2.3

1.9

21.8

21.4

0.46

237

1393

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

185

1059

1.77

11.93

1.7

1.3

e6/l

40.0

23.8

0.23

147

828

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

451

2.19

11.89

1.2

u/l

49.7

57.3

1.07

296

(3014891) Appearance of Pleural fluid

4.67

11.86

1.7

1.6

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

185

1061

1.77

11.86

1.8

1.4

e6/l

549.2

1037.9

0.49

152

878

(3048879) Bone marrow aspiration report

106

3.60

11.85

1.7

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

4.15

11.76

1.6

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

121

3.40

11.75

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

203

1199

1.72

11.74

1.6

1.2

mg/l

522.9

523.9

0.01

191

1119

(40761511) CBC panel - Blood by Automated count

5240

50290

1.32

11.60

29.1

12.8

—

(3019977) pH of Arterial blood

287

2.49

11.58

3.1

2.2

7.4

1.09

107

(3004451) EKG impression Narrative

258

2.58

11.54

1.2

1.3

—

(3044889) 12 lead EKG panel

3773

34986

1.21

11.05

4.6

4.0

—

(3007461) Platelets [#/volume] in Blood

5557

53886

1.40

10.86

47.7

19.4

e9/l

240.4

244.7

4.24

5478

52259

(3035933) Granulocytes/100 leukocytes in Blood

3.63

10.77

3.2

1.7

—

(3012516) Albumin [Mass/volume] in Urine

1432

16752

0.81

10.62

3.2

3.3

mg/l

678.8

279.1

1.84

953

10721

(3035941) MCH [Entitic mass]

5557

53912

1.39

10.59

47.4

19.3

30.3

30.4

2.88

5510

52975

(40761539) Cells [Type] in Urine sediment by Light microscopy

100

3.51

10.57

1.3

1.2

—

(3024731) MCV [Entitic volume]

5557

53914

1.39

10.56

47.4

19.4

91.7

91.3

8.05

5508

52974

(3026361) Erythrocytes [#/volume] in Blood

5557

53920

1.39

10.50

47.6

19.4

e12/l

4.2

4.5

302.23

5466

52095

(3010813) Leukocytes [#/volume] in Blood

5557

53926

1.39

10.44

47.7

19.4

e9/l

6.8

6.7

0.97

5473

52097

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

+∞

10.42

1.0

0.0

—

(3000963) Hemoglobin [Mass/volume] in Blood

5557

53928

1.39

10.41

47.8

19.5

g/l

126.5

136.9

307.65

5509

53000

(3009445) Proteinase 3 Ab [Units/volume] in Serum

327

2233

1.49

10.31

1.3

1.5

u/ml

8.9

17.1

—

(3009508) Creatinine [Moles/volume] in Urine

1493

17342

0.82

10.25

3.1

3.2

mmol/l

7.4

7.6

1.40

1230

14524

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

3.49

9.87

1.9

2.8

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

256

2.44

9.73

1.1

1.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

116

3.20

9.70

1.3

2.4

e6/l

4789.5

29977.9

0.79

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

257

2.43

9.65

1.1

1.0

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

496

3708

1.37

9.48

3.3

3.9

ng/l

85.6

95.2

1.33

425

3129

(3000570) Elastase.pancreatic [Mass/mass] in Stool

213

1352

1.60

9.38

1.4

ug/g

256.1

292.9

1.83

127

795

(3003181) Sodium [Moles/volume] in Urine

146

842

1.75

9.27

1.3

1.4

mmol/l

63.2

64.6

0.15

119

679

(3022145) Colonoscopy Study observation

630

4906

1.32

9.15

1.3

—

(40768443) Skin Pathology biopsy report

290

1990

1.48

8.96

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1544

17694

0.83

8.93

3.9

4.0

mg/mmol

11.1

8.7

1.19

1057

11295

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

230

2.45

8.92

1.1

u/l

91.7

90.3

0.04

173

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

231

3439

0.66

8.80

1.6

1.8

—

(3036603) Volume of Urine

295

2.25

8.70

1.6

1.4

1972.9

1972.3

0.00

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1324

11316

1.22

8.70

1.8

1.7

pmol/l

17128026.8

31765255.8

0.72

1121

9287

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

3.61

8.54

1.4

1.2

ng/l

103.4

137.2

0.27

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

229

2.41

8.53

1.1

u/l

26.9

22.9

0.37

165

(3023487) Leukocytes [#/volume] in Peritoneal fluid

137

2.86

8.46

1.4

2.7

e6/l

2548.7

643.3

0.68

101

(3044242) Glucose [Moles/volume] in Arterial blood

262

2.30

8.37

1.4

1.6

—

(1002224) Polysomnography panel

1737

0.54

8.32

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

178

2.60

8.31

40.1

26.6

ug/l

113.2

114.0

0.03

140

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

269

1848

1.48

8.29

2.0

2.3

ug/l

307.7

639.4

1.32

246

1745

(3018834) Bilirubin.total [Presence] in Urine by Test strip

14.47

8.19

3.4

1.3

estimate

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

14.47

8.19

1.2

1.3

—

(3024869) Neuronal Ab [Presence] in Serum

3.34

8.19

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

458

1.96

8.15

1.2

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2917

26822

1.17

8.14

2.8

2.6

—

(40768797) Stomach Pathology biopsy report

816

6666

1.26

8.12

1.3

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

135

2.83

8.09

1.8

1.7

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

7.07

7.99

1.5

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1541

0.53

7.89

1.3

1.7

mg/l

4.3

3.9

0.18

1092

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

154

2.67

7.87

3.8

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

154

2.67

7.87

3.8

2.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

220

1467

1.52

7.85

1.5

1.6

iu/ml

0.3

2.3

0.52

320

(3052851) Hemolysis interference index of Serum or Plasma

207

1365

1.53

7.79

3.5

3.4

—

(3016018) Differential panel - Cerebral spinal fluid

467

1.92

7.73

1.7

1.3

—

(3024932) HLA-DR beta [Type]

128

2.82

7.67

1.4

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

167

1053

1.60

7.64

1.6

1.2

mmol/l

3.8

3.9

0.72

154

979

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.27

7.64

1.7

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

626

7772

0.78

7.58

1.2

1.3

u/ml

9.1

14.8

1.83

243

2920

(3040151) Glucose [Moles/volume] in Capillary blood

104

579

1.81

7.52

6.7

18.7

mmol/l

6.7

7.4

2.02

469

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

509

1.86

7.43

1.1

—

(3024471) HLA-A [Type]

131

2.76

7.36

1.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

278

2.17

7.32

1.6

1.5

u/l

3.9

5.1

0.42

122

(21494755) Public health laboratory ask at order entry panel

231

3313

0.69

7.29

1.2

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

252

1758

1.45

7.22

1.6

titre

480.7

312.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

143

2260

0.62

7.22

1.3

1.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

5.66

7.06

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

433

1.91

7.02

1.3

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

225

2.28

7.01

1.0

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3888

36768

1.16

6.96

4.9

3.8

pmol/l

15.0

14.9

3.33

3613

33065

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

797

6605

1.24

6.94

1.4

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

6.48

6.77

1.6

1.5

mg/l

1.0

1.5

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

6.48

6.77

1.6

1.5

mg/l

0.6

0.8

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

6.48

6.77

1.6

1.5

mg/l

1.1

0.6

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.26

6.74

1.1

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

678

8213

0.80

6.57

1.2

1.3

iu/ml

39.9

36.4

0.23

204

2495

(3021960) Folate [Moles/volume] in Serum or Plasma

1380

12117

1.18

6.51

1.6

1.5

nmol/l

19.2

20.2

1.74

1224

10268

(3019309) Folate [Moles/volume] in Red Blood Cells

1181

10233

1.19

6.50

1.8

nmol/l

1165.9

1151.1

0.22

957

7705

(4010399)

281

3813

0.72

6.44

1.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

5.46

6.28

1.9

1.7

—

(3023410) Appearance of Cerebral spinal fluid

429

1.85

6.26

2.1

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

110

2.74

6.10

1.1

1.9

g/l

14.1

13.7

0.09

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

130

820

1.60

6.03

1.2

—

(1761868) Lipid panel - Serum or Plasma

1428

16042

0.86

6.01

3.1

—

(3022475) Manganese [Moles/volume] in Blood

6.26

5.95

1.6

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

132

839

1.59

5.93

2.8

1.2

u/l

95.3

27.6

1.52

114

716

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

249

2.10

5.91

2.9

4.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1803

16275

1.15

5.85

2.2

u/l

165.3

230.2

3.42

1705

15179

(3021387) Prolactin [Units/volume] in Serum or Plasma

161

1077

1.51

5.77

1.6

1.7

mu/l

291.4

298.9

0.11

155

979

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

398

1.84

5.74

2.2

2.3

u/field

1.6

1.7

0.14

157

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

127

808

1.58

5.70

1.1

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

4487

43126

1.16

5.68

29.7

14.5

36.9

39.8

47.84

2796

28982

(21494890) Protein electrophoresis panel - 24 hour Urine

458

1.78

5.67

1.6

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

290

1.97

5.53

1.5

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

413

5194

0.78

5.53

1.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

154

1031

1.51

5.52

1.4

1.8

iu/l

4.9

4.7

0.05

340

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

291

1.97

5.48

1.5

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

158

1067

1.49

5.43

1.2

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

16.02

5.41

1.0

—

(3033799) Differential panel - Peritoneal fluid

118

2.55

5.36

1.3

2.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

614

5089

1.23

5.33

2.2

2.4

ug/l

7.8

8.0

0.06

545

4452

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

192

1353

1.43

5.31

1.3

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

193

1362

1.43

5.30

1.3

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

341

2642

1.31

5.20

1.2

iu/ml

97.7

128.5

0.91

983

(42529406) Shigella sp [Presence] in Stool by Culture

193

1369

1.42

5.16

1.3

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

997

0.54

5.04

1.5

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

5.27

5.03

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

100

2.61

4.88

1.4

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

255

1.97

4.86

1.7

1.9

u/field

2.4

2.5

0.03

173

(3032057) Clostridioides difficile [Presence] in Stool

107

2.53

4.78

1.7

1.8

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

239

1.97

4.62

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

457

1.69

4.62

2.8

3.9

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

194

1408

1.39

4.59

1.5

g/l

1.2

0.01

187

1327

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

4.77

4.53

5.3

1.1

pmol/l

40.1

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

113

743

1.53

4.48

1.4

1.6

g/l

0.9

0.8

0.14

562

(3051611) Lipemic interference index of Serum or Plasma

465

1.66

4.36

3.5

3.6

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

4.24

4.35

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

519

1.63

4.35

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

3.51

4.32

1.1

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

865

9876

0.86

4.32

1.2

1.3

u/ml

1.0

2.0

5.58

208

2585

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

187

1374

1.37

4.15

1.5

g/l

0.2

0.01

179

1299

(3013945) Hepatitis B virus e Ab [Presence] in Serum

4.35

4.08

2.1

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

254

3263

0.77

4.07

1.2

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.43

3.96

1.4

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

488

1.61

3.88

1.4

g/l

6.9

6.8

0.07

342

(3028192) IgG subclass 2 [Mass/volume] in Serum

488

1.61

3.88

1.4

g/l

2.3

2.9

2.29

343

(3024139) IgG subclass 3 [Mass/volume] in Serum

488

1.61

3.88

1.4

g/l

0.4

0.22

344

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

157

1136

1.39

3.85

1.2

1.3

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

6.01

3.81

1.8

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.80

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

671

0.52

3.80

1.2

1.1

u/ml

1.9

1.7

0.07

267

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.43

3.79

1.2

1.3

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

12.01

3.76

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

195

1.95

3.71

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

259

2031

1.29

3.70

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

550

1.55

3.69

1.4

1.2

u/ml

61.7

39.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

245

1.84

3.69

1.3

1.2

u/l

47.8

19.0

1.49

211

(4062490)

488

1.59

3.66

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

121

845

1.44

3.64

2.7

3.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.75

3.58

1.8

1.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

301

1.73

3.50

1.2

1.1

mg/l

343.5

281.2

0.69

267

(3047189) Immunofixation for 24 hour Urine

186

1.94

3.47

1.7

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.76

3.41

1.1

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

108

2.23

3.31

1.1

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

317

1.68

3.20

1.1

mg/l

55.7

39.5

0.89

263

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

6.37

3.18

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

566

0.53

3.15

1.1

u/ml

0.4

1.2

1.22

231

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

251

1.76

3.15

1.2

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

290

0.34

3.13

1.2

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

511

0.51

3.11

1.1

u/ml

0.1

2.1

—

118

(3007566) Smooth muscle Ab [Titer] in Serum

163

1234

1.33

3.08

1.2

titre

93.2

110.1

0.35

102

(3003888) Timothy IgE Ab [Units/volume] in Serum

585

0.54

3.04

1.1

u/ml

3.8

3.7

0.02

284

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.58

3.04

1.2

1.1

—

(3044007) Cell count panel - Peritoneal fluid

106

2.17

3.02

1.3

2.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

315

1.66

3.02

1.2

—

(4027681)

234

1.76

2.95

1.3

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

639

1.45

2.92

2.1

2.3

mg/l

29.7

23.6

0.47

167

(3019150) Specific gravity of Urine by Refractometry

1194

10916

1.12

2.92

4.5

4.1

kg/l

1.0

0.20

235

1610

(3011325) HIV 1+2 Ab [Presence] in Serum

5.39

2.86

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

255

3125

0.81

2.83

1.7

1.9

—

(3022621) pH of Urine by Test strip

387

3275

1.19

2.82

3.4

2.9

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

147

1113

1.33

2.80

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

116

849

1.37

2.76

1.3

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

1133

0.69

2.70

2.2

2.1

—

(3017704) Immunofixation for Urine

271

1.67

2.70

1.2

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

2.43

2.70

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.50

2.69

1.2

1.1

—

(4015189)

161

1.87

2.65

1.8

2.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

133

1.96

2.64

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.66

2.62

1.0

1.2

—

(3040893) Potassium [Moles/volume] in Capillary blood

4.67

2.59

1.3

3.3

mmol/l

4.9

4.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

214

1.73

2.58

1.3

5.3

mg/l

6449.3

66.9

0.49

148

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

185

1.79

2.56

1.1

ng/l

3373.0

443.3

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

7.15

2.55

4.4

5.4

—

(3016135) IgD [Mass/volume] in Serum

7.15

2.55

1.2

1.0

mg/l

14.1

225.5

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

7.15

2.55

4.4

4.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

230

2812

0.81

2.53

1.6

1.9

—

(3003740) Influenza virus B Ag [Presence] in Specimen

517

1.46

2.53

1.3

1.1

—

(40761535) Cells panel - Urine sediment

500

4367

1.16

2.50

3.6

3.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4747

48434

0.91

2.50

4.9

mmol/l

6.0

0.16

4332

43924

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

158

1.84

2.47

1.3

1.2

10.5

43.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.67

2.45

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

159

1.83

2.43

1.3

1.1

g/l

1.2

0.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

5.00

2.40

1.0

—

(4038314)

5.00

2.40

1.0

1.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

128

975

1.32

2.39

1.5

1.2

u/ml

1.1

4.4

1.05

(44816559) Phosphatidylethanol [Mass/volume] in Blood

870

0.67

2.38

1.3

—

(36660697) Celiac disease serology panel - Serum

303

3584

0.84

2.38

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

235

1.66

2.38

1.1

1.0

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

6.25

2.37

1.0

—

(3027944) Amphetamines [Presence] in Urine

1068

0.71

2.36

1.3

2.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

519

1.43

2.31

1.3

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

405

1.49

2.28

1.1

—

(3028300) Cannabinoids [Presence] in Urine

1092

0.72

2.24

1.5

2.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

443

0.56

2.23

1.1

u/ml

0.4

3.4

—

171

(4094501)

114

1485

0.76

2.18

1.1

—

(3027008) Opiates [Presence] in Urine

1086

0.72

2.18

1.3

2.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

459

5211

0.87

2.16

1.6

1.8

1.6

1.5

0.88

402

4496

(3000764) Benzodiazepines [Presence] in Urine

1082

0.73

2.14

1.3

2.0

—

(3017569) Oxygen content in Arterial blood

275

1.57

2.10

1.9

1.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1216

0.74

2.10

1.5

1.8

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

116

1.90

2.10

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

580

1.38

2.10

1.4

1.3

nmol/l

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.71

2.10

1.3

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.71

2.10

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

409

0.56

2.09

1.1

u/ml

1.3

4.1

—

157

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2154

20513

1.08

2.09

7.8

3.9

ug/l

10.7

2.2

2.98

1973

18457

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

463

1.43

2.09

1.0

1.1

—

25.9

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

135

1060

1.28

2.06

3.1

nmol/l

0.9

0.8

0.27

826

(3003338) MCHC [Mass/volume]

4164

40636

1.08

2.05

39.9

17.3

g/l

330.8

332.7

34.54

4137

40311

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.32

2.04

1.2

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

324

2787

1.17

2.03

1.4

1.3

u/ml

256.3

243.4

0.07

287

2576

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

111

1.90

2.00

1.1

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

4.55

1.94

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

226

1.60

1.92

1.1

u/l

1.1

0.03

102

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

234

1.58

1.92

1.2

1.6

—

(3006270) Folate [Moles/volume] in Blood

463

1.41

1.92

1.1

1.2

nmol/l

349.5

341.6

0.12

379

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.65

1.86

1.1

—

(3016879) Cocaine [Presence] in Urine

1019

0.74

1.84

1.3

2.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

4.17

1.82

1.0

—

(3008898) HLA-B27 [Presence]

106

1350

0.78

1.77

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

124

1.78

1.75

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

3.34

1.74

1.2

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

592

1.34

1.74

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.22

1.73

2.3

1.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

257

1.52

1.72

2.8

1.8

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.67

1.72

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

184

2200

0.83

1.71

1.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

121

1510

0.80

1.71

1.7

1.9

—

(3001729) Color of Synovial fluid

2.29

1.70

2.2

1.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

365

1.43

1.69

1.1

1.3

mmol/l

11.3

11.6

0.11

102

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

595

1.33

1.69

1.4

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.10

1.65

1.1

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

113

898

1.26

1.63

1.5

1.2

u/ml

41.4

40.0

0.04

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

127

1.73

1.63

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

597

6548

0.90

1.63

3.9

4.9

30.8

32.5

3.15

416

4393

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

341

0.59

1.62

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

661

1.31

1.61

1.4

1.3

nmol/l

0.1

0.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.50

1.59

1.0

—

(3045414) Leukocytes [Presence] in Urine

187

2212

0.84

1.57

2.0

1.9

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

175

1.60

1.57

1.2

1.3

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

174

0.46

1.57

4.1

2.4

nmol/l

172.8

143.7

—

155

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

139

1690

0.82

1.57

1.7

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

129

1.71

1.56

3.1

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

144

1184

1.22

1.55

1.5

1.2

u/ml

5.7

5.4

0.04

191

(3003327) Ova and parasites identified in Stool by Light microscopy

169

1412

1.20

1.55

1.8

—

(40757494) Bilirubin.total [Moles/volume] in Blood

297

1.45

1.55

2.4

2.0

umol/l

20.9

16.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

122

1.72

1.54

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.43

1.53

1.9

2.5

—

(3021788) Differential panel - Synovial fluid

1011

0.77

1.53

1.7

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

396

0.63

1.53

1.3

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

241

1.50

1.51

2.5

2.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

138

1.67

1.51

1.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.16

1.50

1.0

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

142

1172

1.22

1.49

1.5

1.2

u/ml

2.3

5.0

0.52

122

(3016750) Collection duration of Urine

325

1.42

1.48

2.2

min

506.3

496.1

0.39

255

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

230

0.52

1.48

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

857

0.76

1.46

1.3

2.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

576

1.31

1.45

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

425

0.66

1.43

1.6

1.7

—

(3036071) Salmonella sp Ab [Titer] in Serum

136

0.44

1.39

1.2

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.18

1.39

1.0

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

151

1266

1.20

1.37

1.4

1.2

u/ml

47.3

39.9

0.12

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.20

1.36

1.2

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.61

1.36

4.0

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

538

0.70

1.36

1.2

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

199

1.51

1.34

1.1

1.2

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

1.33

0.0

1.9

—

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

128

1.64

1.33

1.0

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

453

0.68

1.33

1.0

ng/l

30.9

45.5

3.36

287

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

0.00

1.31

0.0

1.1

—

12.4

—

(3026480) Teichoate Ab [Titer] in Serum

2.09

1.30

1.1

1.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

450

0.69

1.29

1.0

ng/l

953.6

723.8

2.07

282

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.78

1.28

1.4

1.1

nmol/l

302.8

249.6

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

1.89

1.28

1.2

1.1

65.6

50.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

114

1.67

1.28

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

449

0.69

1.27

1.0

ng/l

252.6

339.1

3.28

290

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.94

1.27

1.1

1.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.00

1.27

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.40

1.24

1.0

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1721

16517

1.06

1.23

6.2

3.8

21.6

24.1

9.45

979

8027

(3028717) Thiamine [Mass/volume] in Blood

2.00

1.23

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.00

1.23

1.8

2.8

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

131

1.61

1.23

1.3

—

(3044927) Protein electrophoresis panel - Urine

568

1.27

1.18

1.1

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1027

0.81

1.18

1.5

1.6

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.88

1.18

2.0

1.6

—

(44806420)

173

1.51

1.17

2.2

2.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

190

1.48

1.16

1.3

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1057

0.81

1.15

1.7

1.9

pmol/l

200.0

0.00

993

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

120

1.59

1.08

1.1

76.1

86.7

0.47

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.19

1.08

1.0

1.3

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

487

1.28

1.08

1.4

—

45.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

350

0.68

1.06

2.0

1.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4549

44880

1.06

1.05

5.7

4.6

mu/l

2.2

2.0

2.90

4217

40660

(3037522) Nuclear Ab [Titer] in Serum

682

6389

1.08

1.04

1.4

1.3

titre

601.3

512.3

0.54

158

1341

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

288

1.36

1.04

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

315

1.34

1.02

1.3

1.9

umol/l

4.4

7.5

1.76

213

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

122

1.56

1.02

1.1

79.7

86.1

0.30

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.89

1.01

1.4

2.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.95

0.97

2.4

3.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.85

0.96

2.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

165

1.46

0.96

1.0

—

(3024928) Oxygen saturation in Venous blood

124

1063

1.17

0.95

3.0

3.4

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.22

0.93

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

117

1.54

0.93

2.1

2.6

mmol/l

6.4

8.0

2.21

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.73

0.92

2.3

2.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.14

0.91

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

118

1.53

0.90

1.0

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

102

1.57

0.90

1.5

2.2

mmol/l

1.2

0.45

102

(4198724)

154

0.58

0.88

1.2

1.8

—

(3022689) Creatine [Moles/volume] in Urine

181

0.61

0.87

1.5

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

286

0.70

0.84

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

136

1551

0.87

0.83

1.6

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

543

1.22

0.82

1.7

1.3

e6/l

117054.1

180825.9

0.33

381

(3004775) Volume in Urine collected for unspecified duration

480

1.23

0.82

2.3

778.0

631.6

1.24

336

(3000285) Sodium [Moles/volume] in Blood

1.61

0.81

1.2

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

509

0.78

0.79

1.3

2.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

652

0.81

0.79

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.67

0.78

1.4

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

149

0.60

0.78

1.8

1.5

ug/l

8.1

9.3

—

149

(3026250) Tacrolimus [Mass/volume] in Blood

182

1.38

0.77

26.7

34.1

ug/l

8.5

7.5

1.90

169

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.77

0.0

1.1

—

(3003577) Lead [Moles/volume] in Blood

0.00

0.76

0.0

1.2

—

0.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.08

0.74

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

1.84

0.73

1.0

—

(4212803)

1.80

0.72

1.0

—

(3007916) DNA double strand Ab [Titer] in Serum

1.67

0.72

1.1

1.3

—

112.4

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.71

0.70

1.4

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

155

1728

0.89

0.69

1.7

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

178

1.35

0.68

2.4

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

127

1.42

0.67

1.2

1.5

ug/l

0.4

0.3

0.39

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

844

0.85

0.67

1.4

1.5

—

(3044941) Cell count panel - Synovial fluid

864

0.85

0.66

1.8

1.4

—

(3002619) Bacteria identified in Specimen by Culture

1.51

0.66

1.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.59

0.65

1.1

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

201

0.70

0.64

2.0

1.2

—

(3014271) Vancomycin [Susceptibility]

278

1.26

0.63

2.7

3.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

261

1.27

0.62

1.5

1.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.67

0.61

1.2

1.0

—

(3025130) Human papilloma virus identified in Specimen

407

1.21

0.60

1.6

1.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

105

1183

0.89

0.59

1.1

u/ml

3.3

8.1

1.24

118

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.00

0.58

0.0

1.8

—

0.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

193

1.30

0.57

1.2

2.2

umol/l

75.8

145.0

1.47

101

(3000475) Leukocytes [#/volume] in Synovial fluid

124

1379

0.90

0.57

2.0

1.6

e6/l

14467.3

13042.8

0.13

101

1004

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

331

0.78

0.57

1.1

1.3

u/ml

1.3

1.1

—

160

(3036670) Protein [Mass/volume] in Synovial fluid

185

1.30

0.56

1.6

1.2

g/l

37.2

39.7

0.44

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

194

0.72

0.54

1.2

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.54

0.53

1.0

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.62

0.52

1.0

1.8

—

116.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

159

1458

1.09

0.50

2.2

2.3

ug/min

126.7

118.6

0.07

874

(3027923) C peptide [Moles/volume] in Serum or Plasma

297

1.21

0.50

1.4

nmol/l

1.2

0.10

232

(40768446) Kidney Pathology biopsy report

180

1.28

0.49

1.4

1.7

—

(3045424) Erythrocytes [Presence] in Urine

821

1.12

0.49

1.9

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

774

1.13

0.49

1.1

iu/ml

47.7

1272.4

0.86

162

(3020874) Milk IgE Ab [Units/volume] in Serum

189

0.74

0.48

1.0

u/ml

0.5

0.8

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

197

1829

1.08

0.48

1.3

1.2

u/ml

3.2

0.8

0.59

179

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

738

1.13

0.47

1.6

—

(3045716) Anion gap in Serum or Plasma

264

1.21

0.45

1.6

2.2

mmol/l

9.5

9.3

0.08

200

(3006462) Nitrate [Presence] in Urine

229

1.22

0.43

3.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.64

0.42

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.56

0.42

10.8

10.3

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

0.64

0.42

1.3

1.5

mu/l

492.7

648.9

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

0.63

0.42

1.3

1.5

81.3

71.4

—

(3048689) Calprotectin [Mass/mass] in Stool

516

5367

0.96

0.42

2.0

2.3

ug/g

211.6

148.2

1.84

416

4202

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.41

0.0

5.7

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.40

0.0

1.0

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

6.7

—

(4306422)

646

0.88

0.40

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

476

0.86

0.40

1.4

1.5

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.40

0.0

5.4

—

374.9

—

(3011288) Drugs identified in Urine by Screen method

718

0.89

0.39

1.6

2.9

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.39

0.0

1.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

251

1.20

0.39

1.2

ratio

1.1

0.33

(3042733) HLA Ab [Presence] in Serum

147

0.75

0.37

4.2

5.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

113

0.71

0.37

1.1

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.30

0.37

7.2

6.4

—

(3026470) Cobalt [Mass/volume] in Blood

407

0.86

0.36

1.8

1.9

ug/l

2.7

3.4

0.58

364

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.27

0.36

1.1

1.0

—

(4146454)

650

0.89

0.36

2.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

437

0.87

0.34

1.3

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

151

1412

1.07

0.34

1.6

1.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

330

0.85

0.34

1.7

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

394

0.86

0.34

1.1

1.4

pmol/l

41.2

154.7

0.72

108

(3038177) Helicobacter pylori Ab [Presence] in Serum

690

1.10

0.34

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

127

1181

1.08

0.34

1.4

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

436

0.87

0.34

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

436

0.87

0.34

1.3

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

538

1.12

0.33

3.2

3.1

mg/l

46.7

45.3

0.02

404

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

435

0.87

0.33

1.3

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

220

0.82

0.32

2.2

2.3

umol/l

56.3

56.4

0.00

182

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

612

0.90

0.31

1.1

1.2

123.1

115.1

0.83

546

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

643

0.90

0.31

1.2

u/ml

1.7

4.4

4.74

293

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

379

0.87

0.30

1.1

1.4

—

322.6

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

153

0.78

0.30

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

153

0.78

0.30

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

153

0.78

0.30

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

153

0.78

0.30

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

324

1.14

0.30

2.2

2.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.27

0.30

1.4

1.7

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

477

1.11

0.29

1.3

nmol/l

1.3

1.5

0.64

430

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

575

1.10

0.27

1.2

1.3

mmol/l

8.1

7.7

0.41

411

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

188

1.17

0.25

1.0

1.1

miu/ml

954.8

1626.8

2.62

188

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

333

3222

1.04

0.24

2.3

2.4

au/ml

11.0

24.9

—

140

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

218

1.15

0.23

1.1

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

153

1.18

0.22

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.21

0.0

1.2

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.21

0.0

4.8

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.3

—

3.5

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

2.4

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

101

0.79

0.21

1.6

1.5

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.16

0.21

1.6

1.1

u/l

20.0

9.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

635

0.93

0.20

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.20

0.19

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

375

0.91

0.19

1.4

1.5

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.18

0.19

13.8

9.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

654

0.93

0.19

1.2

u/ml

2.4

4.0

0.52

211

(3023511) Choriogonadotropin [Units/volume] in Urine

395

0.91

0.19

1.5

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1.23

0.18

1.6

1.3

nmol/l

32.4

30.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

531

1.07

0.18

1.8

1.5

29.5

29.1

0.03

347

(3020491) Glucose [Moles/volume] in Blood

373

0.91

0.18

1.4

2.2

mmol/l

7.3

6.7

0.49

249

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

670

6816

0.98

0.18

11.8

7.0

—

(3000492) Spirometry study

453

4434

1.02

0.17

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

110

1.18

0.17

1.9

1.8

—

(3032773) Endomysium IgG Ab [Titer] in Serum

381

0.92

0.16

1.1

—

(4211845)

254

1.10

0.16

3.3

3.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.10

0.15

1.3

1.7

—

(44813793)

307

0.91

0.15

1.1

—

(3024263) Appearance of Synovial fluid

296

0.91

0.14

2.2

1.6

—

(3011985) Renin [Units/volume] in Plasma

664

1.05

0.14

1.5

1.3

mu/l

66.6

66.3

0.00

586

(3051593) INR in Capillary blood by Coagulation assay

275

0.91

0.14

13.2

10.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

337

0.92

0.14

1.8

1.4

g/l

0.9

0.51

337

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2155

21692

0.99

0.14

1.9

2.0

pmol/l

91.0

94.6

3.24

1280

11243

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

539

5477

0.98

0.14

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1152

11634

0.99

0.13

4.0

3.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

218

1.10

0.13

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

113

1.15

0.13

1.1

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

285

2791

1.02

0.12

2.3

2.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

365

0.93

0.12

1.3

1.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

137

0.88

0.12

7.1

7.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

178

0.90

0.11

1.3

1.5

—

(3005033) Fetal Nuchal fold Thickness US

363

0.94

0.11

1.3

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

291

0.93

0.11

2.2

2.1

ug/min

232.6

215.7

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

163

1.10

0.10

1.3

2.0

ug/l

42.8

59.8

0.95

158

(3019174) dRVVT (LA screen)

1.09

0.09

1.0

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

153

1495

1.02

0.09

1.9

1.8

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

233

1.07

0.09

1.1

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.07

0.08

1.2

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

103

1059

0.97

0.08

1.5

1.8

nmol/l

0.9

0.8

0.84

870

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.09

0.08

3.3

2.6

u/field

0.6

0.5

—

(3020650) Glucose [Presence] in Urine

117

1.11

0.08

1.0

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.84

0.07

10.7

11.9

mmol/l

5.0

5.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

225

0.93

0.07

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

143

0.91

0.07

1.0

1.8

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.83

0.07

1.0

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

296

2926

1.01

0.06

1.2

1.3

au/ml

84.6

51.2

—

123

(3020191) Ethanol [Moles/volume] in Serum or Plasma

404

1.04

0.06

1.4

promille

0.9

1.3

0.79

310

(4034850)

179

1763

1.02

0.06

12.4

9.8

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

179

1.06

0.05

1.0

1.1

98.4

93.3

0.38

133

(3015183) Erythrocyte sedimentation rate

179

1.06

0.05

1.1

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

272

0.96

0.04

1.8

1.5

4.3

4.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1155

11516

1.00

0.03

3.4

2.8

ug/l

1.0

0.7

5.69

826

7901

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

169

0.95

0.03

1.1

—

(4133840)

118

0.93

0.02

1.5

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

241

1.04

0.02

1.2

nmol/l

144.7

139.2

0.14

241

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

400

1.03

0.02

1.2

u/ml

99.6

68.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

152

1.05

0.02

1.3

1.6

mmol/l

7.3

8.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

541

1.02

0.02

1.1

u/ml

1.7

3.1

1.47

225

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

719

0.99

0.01

1.7

1.5

65.6

60.6

0.65

467

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

163

1.04

0.01

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

618

0.99

0.01

1.5

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

333

1.02

0.01

1.2

1.1

—

(3011648) Oxygen content in Venous blood

383

1.02

0.01

2.5

2.4

10.8

11.2

0.26

383

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

104

1.06

0.01

1.5

1.7

ng/l

106.9

125.8

0.26

104

(3051101) Glucose [Moles/volume] in Cord blood

116

0.95

0.00

4.5

6.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

116

0.95

0.00

6.6

7.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

311

3103

1.00

0.00

1.4

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

334

1.02

0.00

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

334

1.02

0.00

1.2

1.1

—

(4024509)

496

0.99

0.00

1.5

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

626

0.99

0.00

1.3

pmol/l

310.8

271.4

0.36

471

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

135

1.04

0.00

1.3

1.2

111.7

112.2

0.02

116

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

388

1.01

0.00

1.3

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

124

0.97

0.00

1.2

1.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

146

1.03

0.00

1.2

g/l

0.3

0.48

114

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

156

1.03

0.00

6.5

7.4

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

107

1.03

0.00

1.0

u/ml

0.9

1.8

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

336

1.01

0.00

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

336

1.01

0.00

1.2

1.1

—

(4268621)

444

0.99

0.00

2.1

2.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

337

1.01

0.00

1.2

1.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

453

0.99

0.00

3.9

2.8

13.5

13.2

1.06

448

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

141

0.99

0.00

1.1

1.7

—

(3034426) Prothrombin time (PT)

159

1.01

0.00

1.3

1.2

—

(3036180) Methadone [Presence] in Urine

0.00

0.0

2.8

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.85

0.00

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.88

0.00

1.0

1.1

u/ml

24.8

57.9

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

35.6

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.2

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.0

1.5

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

138.7

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

7.4

—

0.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

140

1.00

0.00

1.2

1.7

210.6

183.5

0.43

131

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

2.0

—

1.8

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.95

0.00

1.1

1.5

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.4

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_LYMPHNODES_SECONDARY_NAS_EXALLC – Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers) (C3_LYMPHNODES_SECONDARY_NAS_EXALLC)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints